
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5335448AF2B663053544005E991298.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer">
<meta name="citation_author" content="Seyedeh Fatemeh Ahmadi">
<meta name="citation_author_institution" content="Department of Biology, CT.C. Islamic Azad University, Tehran, Iran">
<meta name="citation_author" content="Seyed Shahriar Arab">
<meta name="citation_author_institution" content="Center for Molecular Medicine, Georgia University, Athens, USA">
<meta name="citation_author" content="Hamidreza Samadikhah">
<meta name="citation_author_institution" content="Department of Biology, CT.C. Islamic Azad University, Tehran, Iran">
<meta name="citation_author_institution" content="Department of Tissue Engineering and Regenerative Medicine Institute, Central Tehran Branch, Islamic Azad University, Tehran, Iran">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30599">
<meta name="citation_doi" content="10.1038/s41598-025-13110-3">
<meta name="citation_pmid" content="40835666">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/pdf/41598_2025_Article_13110.pdf">
<meta name="description" content="Evidence indicates that the survivin protein is overexpressed in various types of cancer. Survivin belongs to the inhibitors of apoptosis proteins (IAPs) family, which plays a crucial role in preventing apoptosis and regulating the cell cycle. This ...">
<meta name="og:title" content="Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Evidence indicates that the survivin protein is overexpressed in various types of cancer. Survivin belongs to the inhibitors of apoptosis proteins (IAPs) family, which plays a crucial role in preventing apoptosis and regulating the cell cycle. This ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368056">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-13110-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_13110.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368056%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368056/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368056/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 20;15:30599. doi: <a href="https://doi.org/10.1038/s41598-025-13110-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-13110-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmadi%20SF%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Seyedeh Fatemeh Ahmadi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Seyedeh Fatemeh Ahmadi</span></h3>
<div class="p">
<sup>1</sup>Department of Biology, CT.C. Islamic Azad University, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmadi%20SF%22%5BAuthor%5D" class="usa-link"><span class="name western">Seyedeh Fatemeh Ahmadi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arab%20SS%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Seyed Shahriar Arab</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Seyed Shahriar Arab</span></h3>
<div class="p">
<sup>2</sup>Center for Molecular Medicine, Georgia University, Athens, USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arab%20SS%22%5BAuthor%5D" class="usa-link"><span class="name western">Seyed Shahriar Arab</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Samadikhah%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hamidreza Samadikhah</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hamidreza Samadikhah</span></h3>
<div class="p">
<sup>1</sup>Department of Biology, CT.C. Islamic Azad University, Tehran, Iran </div>
<div class="p">
<sup>3</sup>Department of Tissue Engineering and Regenerative Medicine Institute, Central Tehran Branch, Islamic Azad University, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Samadikhah%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamidreza Samadikhah</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Biology, CT.C. Islamic Azad University, Tehran, Iran </div>
<div id="Aff2">
<sup>2</sup>Center for Molecular Medicine, Georgia University, Athens, USA </div>
<div id="Aff3">
<sup>3</sup>Department of Tissue Engineering and Regenerative Medicine Institute, Central Tehran Branch, Islamic Azad University, Tehran, Iran </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 28; Accepted 2025 Jul 22; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368056  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40835666/" class="usa-link">40835666</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Evidence indicates that the survivin protein is overexpressed in various types of cancer. Survivin belongs to the inhibitors of apoptosis proteins (IAPs) family, which plays a crucial role in preventing apoptosis and regulating the cell cycle. This protein has a multifaceted function in the cell cycle, particularly in regulating mitosis and cytokinesis. Survivin binds to XIAP, enhancing its stability, and interactively inhibiting caspase-9 activity. Additionally, survivin inhibits apoptosis by inactivating the Smac/DIABLO factor. In this study, we investigated the dual role of peptides in disrupting cell division and inducing apoptosis. Specifically, we designed anti-cancer peptides derived from the Borealin protein. Through single-point mutations, we developed several peptide variants and evaluated their efficacy using bioinformatics approaches, including molecular docking and molecular dynamics simulations. Based on these analyses, we identified P2 and P3 peptides as candidates with the highest binding affinities. Subsequently, the P3 was synthesized for experimental validation. By targeting key mechanisms involved in cancer cell survival and proliferation, P3 demonstrates significant potential as a novel anti-cancer agent with reduced side effects. These findings mark an important step forward in the development of more effective cancer therapies.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-13110-3.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Survivin, Anti-cancer peptide, Cancer, Molecular dynamics (MD) simulation, Apoptosis</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Biological techniques, Biophysics, Biotechnology, Cancer, Cell biology, Computational biology and bioinformatics</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">The functional characteristics of Survivin make it a distinctive protein with diverse roles, including the regulation of cell proliferation and apoptosis. Its expression pattern is also unique; Survivin is prominently expressed during embryonic development and in fetal tissues, but is largely absent in most normal and differentiated tissues<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. However, it is highly expressed in various human cancers<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup> (Supplementary Table 1). In cancer cells, Survivin is frequently associated with increased cell proliferation, resistance to chemotherapy, reduced apoptosis, cellular stress, and cancer recurrence<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>,<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. Survivin belongs to the Inhibitor of Apoptosis Protein (IAP) family<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. Apoptosis plays a crucial role in suppressing cancer progression by eliminating abnormal cells. It also helps contribute to the removal of self-reactive lymphocytes from the immune system in autoimmune diseases. In the context of a pathological immune response, Survivin prolongs the survival of self-reactive lymphocytes by inhibiting apoptotic pathways in these cells<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. Additionally, survivin promotes metastasis and enhances the WNT/β-catenin pathway through a PI3K/AKT-dependent mechanism, facilitating self-renewal<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. One of its primary functions is the inhibition of caspase activity. Survivin monomer forms a complex with XIAP, another member of the IAP family<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. This interaction stabilizes XIAP and, in turn, inhibits caspase-9 activity (The interaction between XIAP BIR3 domain and caspase-9 is shown in Supplementary Fig. 1)<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Specifically, Survivin protects XIAP from ubiquitination and proteasomal degradation by binding to it. Another mechanism by which Survivin inhibits apoptosis involves neutralizing the Smac/DIABLO factor. Smac/DIABLO, a mitochondrial protein, initiates intrinsic apoptosis by binding to IAPs and disrupting their interaction with caspases. When Survivin binds to Smac/DIABLO, it suppresses Smac/DIABLO’s ability to interact with IAPs such as XIAP. XIAP, a critical protein in apoptosis inhibition, contains three Baculoviral IAP Repeat(BIR) domains. The third domain, BIR3, directly binds to the N-terminus of Caspase-9, thereby blocking apoptosis<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. It has been demonstrated that four amino acids, at the N-terminus of the SMAC protein (AVPI), bind to the BIR3 domain, inhibiting its function and triggering apoptosis<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>(The interaction between XIAP BIR3 domain and Smac/DIABLO is shown in Supplementary Fig. 2). The<em>BIRC5</em> gene, located in the telomeric region of chromosome 17q25, encodes Survivin<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. This gene consists of four exons and three introns. And through RNA splicing, it generates six protein isoforms: Survivin-WT, − 2B, − 3B, − 3α, –ΔEx3, and − 2α. Among these, WT-survivin and survivin-DEx3 regulate apoptosis, while survivin-3B and WT-survivin are involved in cell cycle regulation<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>–<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Survivin, composed of 142 amino acids with a molecular weight of 16.5 kDa<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>, consists of a 70 amino acid N-terminal BIR domain associated with apoptotic regulation, a C-terminal α-helix critical for mitotic function, and a domain facilitating dimer formation<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>. Found primarily in the cytoplasm and nucleus of tumor cells, survivin is also localized to the mitochondria. It is released in response to cellular stress and inhibits caspase activity in the cytoplasm. In the nucleus, Survivin associates with the kinetochore of metaphase chromosomes in dividing tumor cells.Extracellularly, it has also been identified in exosomes derived from tumor cells (100–400 nm vesicles), which are internalized by neighboring cells<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. The acetylation of survivin at lysine 129 promotes homodimerization (Supplementary Fig. 3) while deacetylation results in monomer formation, which heterodimerizes with CRM1. Survivin’s nuclear export signal (amino acids 89–98), located within the homodimerization domain, allows CRM1binding, facilitating nucleocytoplasmic transport (Supplementary Fig. 4). In the cytoplasm, the non-acetylated monomeric form of Survivin inhibits caspase activation, thereby protecting tumor cells<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>,<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. In the nucleus, monomeric Survivin is a component of the Chromosomal Passenger Complex (CPC), critical for chromosome segregation and cytokinesis during cell division. The CPC is a heterotetrameric complex that localizes to different sites during various stages of mitosis and is crucial for regulating key events in cell division, such as chromosome attachment to microtubules, proper spindle assembly, and cytokinesis<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>,<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. Aurora B kinase is one of the CPC’s enzymatic components; the other three CPC proteins are Inner Centromere Protein (INCENP), survivin, and Borealin (Supplementary Fig. 5). Each of these proteins has specific regulatory functions, and alterations or disruptions in any of the four CPC components can lead to errors in chromosome segregation and cytokinesis, resulting in genomic instability<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. Analysis of these proteins in CPC formation indicates that Aurora B kinase is directed to mitosis by the other three CPC proteins: INCENP, Survivin, and Borealin. INCENP acts as a scaffolding protein, stabilizing the complex. Borealin promotes the association of Survivin with INCENP, and together, Survivin and Borealin connect with Aurora B kinase through INCENP. INCENP binds to Aurora B kinase at its C-terminal IN-box for centromere targeting, and its N-terminal region interacts with Borealin and Survivin<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. This illustrates that the activation of Aurora B kinase depends on various mitotic kinases, including polo-like kinase 1 (PLK1). Additionally, studies reveal that PLK1 phosphorylates survivin at Ser-20<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>. Consequently, survivin triggers the activation of Aurora B kinase, facilitating cell division. In the case of Borealin binding to Survivin, the CPC is formed<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>–<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. During mitosis, the chromosomal passenger complex initially localizes at the inner centromeres during prophase and remains there until the chromosomes align at the metaphase plate. During the transition from metaphase to anaphase, the complex relocates to the newly formed microtubules between the separating chromosomes. Additionally, chromosomal passengers migrate to the cell cortex during anaphase, where the cleavage plane is established. As the cell progresses through telophase and cytokinesis, these proteins accumulate at the midbody and are ultimately discarded when the midbody is externalized, allowing the daughter cells to separate. Although CPC proteins are functionally diverse, their localization is interdependent<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>. Inhibition of CPC complex formation leads to polyploidy, cytokinesis failure, and mitotic arrest. This study focuses on the design and experimental evaluation of a novel peptide that competes with Borealin for binding to Survivin<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>, thereby inhibiting CPC complex formation. Consequently, reduced Survivin levels during the G2/M phase of the cell cycle lead to the cessation of cell division and mitotic catastrophe. On the other hand, disruption of the Survivin-CRM1 interaction triggers apoptosis and has the potential to suppress cancer cell proliferation<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Computational</h3>
<section id="Sec4"><h4 class="pmc_sec_title">Docking</h4>
<p id="Par3">According to the molecular docking analysis, the shared residues of the Survivin protein that bind to anti-cancer peptides are located in the Borealin region and include the linker region of Survivin, with a high score in cluster 0.</p></section></section><section id="Sec5"><h3 class="pmc_sec_title">MD analysis</h3>
<section id="Sec6"><h4 class="pmc_sec_title">Root mean square deviation analysis (RMSD)</h4>
<p id="Par4">The root mean square deviation (RMSD) values of proteins and ligands were calculated against the initial structure in the protein–ligand systems and plotted to compare protein backbone stability (Fig. <a href="#Fig1" class="usa-link">1</a>a–f)<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>. The RMSD of the protein’s backbone (Fig. <a href="#Fig1" class="usa-link">1</a>g–l), specifically from the region where the peptide is attached (the protein linker part), which lies between the two domains of the protein, exhibited fluctuations compared to the domains of the protein.</p>
<figure class="fig xbox font-sm" id="Fig1"><h5 class="obj_head">Fig. 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig1a_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/43a275caa671/41598_2025_13110_Fig1a_HTML.jpg" loading="lazy" id="d33e482" height="805" width="669" alt="Fig. 1"></a></p>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig1b_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/f37ad1e7e377/41598_2025_13110_Fig1b_HTML.jpg" loading="lazy" id="d33e484" height="800" width="669" alt="Fig. 1"></a></p>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig1c_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/9f0abd8d8d83/41598_2025_13110_Fig1c_HTML.jpg" loading="lazy" id="d33e486" height="809" width="669" alt="Fig. 1"></a></p>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig1d_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/fb0203375f01/41598_2025_13110_Fig1d_HTML.jpg" loading="lazy" id="d33e488" height="833" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Root Mean Square Deviation (RMSD) of Survivin protein and systems. RMSD values of the systems and the protein’s backbone are determined through molecular dynamics (MD) simulation at different time levels. The RMSD graphs indicate that all Survivin-peptide complexes exhibit fluctuation amplitudes comparable to those of the Survivin protein, confirming stable peptide interactions throughout the simulation. In each complex, the A domain of Survivin exhibits consistent fluctuations, while the B domain shows greater fluctuations, attributed to the presence of a linker. (<strong>a</strong>) RMSD values of the Survivin-P1 system (purple). (<strong>b</strong>) RMSD values of the Survivin-P2 system (purple). (<strong>c</strong>) RMSD values of the Survivin-P3 system (purple). (<strong>d</strong>) RMSD values of the Survivin-P4 system (purple). (<strong>e</strong>) RMSD values of the Survivin-P5 system (purple). (<strong>f</strong>) RMSD values of the Survivin-P6 system (purple). (<strong>g</strong>) RMSD values of the survivin protein (P1) (yellow). (<strong>h</strong>) RMSD values of the survivin protein (P2) (yellow). (<strong>i</strong>) RMSD values of the survivin protein (P3) (yellow). (<strong>j</strong>) RMSD values of the survivin protein (P4) (yellow). (<strong>k</strong>) RMSD values of the survivin protein (P5) (yellow). (<strong>l</strong>) RMSD values of the survivin protein (P6) (yellow). (<strong>m</strong>) RMSD values of domain A of Survivin protein (P1) (blue). (<strong>n</strong>) RMSD values of domain A of Survivin protein (P2) (blue). (<strong>o</strong>) RMSD values of domain A of Survivin protein (P3) (blue). (<strong>p</strong>) RMSD values of domain A of Survivin protein (P4) (blue). (<strong>q</strong>) RMSD values of domain A of Survivin protein (P5) (blue). (<strong>r</strong>) RMSD values of domain A of Survivin protein (P6) (blue). (<strong>s</strong>) RMSD values of domain B of Survivin protein (P1) (red). (<strong>t</strong>) RMSD values of domain B of Survivin protein (P2) (red). (<strong>u</strong>) RMSD values of domain B of Survivin protein (P3) (red). (<strong>v</strong>) RMSD values of domain B of Survivin protein (P4) (red). (<strong>w</strong>) RMSD values of domain B of Survivin protein (P5) (red). (<strong>x</strong>) RMSD values of domain B of Survivin protein (P6) (red).</p></figcaption></figure><p id="Par5">Due to the presence of a linker in the survivin protein structure, considerable fluctuations were observed in the diagrams. There was no definitive conclusion about the stability of the protein and peptide structure. To address this, the RMSD of the protein domains (A (Fig. <a href="#Fig1" class="usa-link">1</a>m–r), and B (Fig. <a href="#Fig1" class="usa-link">1</a>s–x), and the peptide (Fig. <a href="#Fig2" class="usa-link">2</a>a–f) were calculated separately. The results indicated that both the protein and peptide showed similar RMSD values, suggesting that they fluctuated together during the simulation due to the presence of the linker. The results show that the stability of the six systems was simulated and finally confirmed by the RMSD analysis. The average RMSD value demonstrates that, after 18 ns, the RMSD curves for both protein–ligand systems exhibit nearly the same conformation change pattern within an acceptable range.</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/894064291559/41598_2025_13110_Fig2_HTML.jpg" loading="lazy" id="d33e529" height="813" width="677" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Root Mean Square Deviation (RMSD) of peptides. RMSD values of the peptide’s backbone are determined through molecular dynamics (MD) simulation at different time levels, as shown in the RMSD graphs of the peptides, they exhibit similar fluctuations to their Survivin-peptide complexes,that these comparable fluctuations indicate stable binding of the anticancer peptides to the survivin protein during the simulation. (<strong>a</strong>) RMSD values of the anti-cancer peptide (P1) (black). (<strong>b</strong>) RMSD values of the anti-cancer peptide (P2) (black). (<strong>c</strong>) RMSD values of the anti-cancer peptide (P3) (black). (<strong>d</strong>) RMSD values of the anti-cancer peptide (P4) (black). (<strong>e</strong>) RMSD values of the anti-cancer peptide (P5) (black). (<strong>f</strong>) RMSD values of the anti-cancer peptide (P6) (black).</p></figcaption></figure></section><section id="Sec7"><h4 class="pmc_sec_title">Radius of gyration (Rg)</h4>
<p id="Par6">The radius of gyration (Rg) during MD simulations diagrams shows consistent and steady conformational changes across all systems. This observation implies a stable behavior potential of interaction between each protein and ligand system<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup> (Fig. <a href="#Fig3" class="usa-link">3</a>a–f).</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/5255c5bbaaf5/41598_2025_13110_Fig3_HTML.jpg" loading="lazy" id="d33e570" height="1063" width="716" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The radius of the gyration(Rg). The Rg graph of systems remains stable during the (100 ns) simulation,as observed in the Rg graphs, the binding of the anticancer peptide to the survivin protein during the simulation does not disrupt the protein fold, demonstrating a stable and consistent fluctuation range. (<strong>a</strong>) Rg values of the Survivin-P1 system. (<strong>b</strong>) Rg values of the Survivin-P2 system. (<strong>c</strong>) Rg value of the Survivin-P3 system. (<strong>d</strong>) Rg values of the Survivin-P4 system. (<strong>e</strong>) Rg values of the Survivin-P5 system. (<strong>f</strong>) Rg values of the Survivin-P6 system.</p></figcaption></figure></section><section id="Sec8"><h4 class="pmc_sec_title">GROMACS protein–ligand interaction energy analysis</h4>
<p id="Par7">To recalculate the system energy from the existing simulation path, we called mdrun with the rerun option. The total interaction energy was calculated and plotted for six protein-peptide systems. The average short-range Coulombic interaction energy for P1, P2, P3, P4, P5, and P6 peptides, respectively, are (− 215.865 kJ mol<sup>−1</sup>, − 232.263 kJ mol<sup>−1</sup>, − 229.382 kJ mol<sup>−1</sup>, − 216.896 kJ mol<sup>−1</sup>, − 157.223 kJ mol<sup>−1</sup>, − 212.905 kJ mol<sup>−1</sup>). The short-range Lennard–Jones energy for P1, P2, P3, P4, P5, and P6 peptides, respectively, is (− 195.9 kJ mol<sup>−1</sup>, − 200.542 kJ mol<sup>−1</sup>, − 189.717 kJ mol<sup>−1</sup>, − 198.668 kJ mol<sup>−1</sup>, − 169.833 kJ mol<sup>−1</sup>, − 202.029 kJ mol<sup>−1</sup>). The average calculation results of both the Coulombic interaction energy and the short-range Lennard–Jones energy for Survivin-P1, Survivin-P2, Sutrvivin-P3, Survivin-P4, Survivin-P5, and Survivin-P6 respectively are (− 411.764, − 432.805, − 419.099, − 415.564, − 327.56, − 414.934) (Fig. <a href="#Fig4" class="usa-link">4</a>a–f).</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/8c37ceaf9628/41598_2025_13110_Fig4_HTML.jpg" loading="lazy" id="d33e633" height="815" width="677" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The GROMACS Interaction energy (IE). The Average of Coulombic IE and Lennard–Jones IE were calculated with the help of protein–ligand analysis by GROMACS software version 2023. (<strong>a</strong>) IE values of the Survivin-P1 system. (<strong>b</strong>) IE values of the Survivin-P2 system. (<strong>c</strong>) IE value of the Survivin-P3 system. (<strong>d</strong>) IE values of the Survivin-P4 system. (<strong>e</strong>) IE values of the Survivin-P5 system. (<strong>f</strong>) IE values of the Survivin-P6 system.</p></figcaption></figure></section><section id="Sec9"><h4 class="pmc_sec_title">gmx_MMPBSA analysis</h4>
<p id="Par8">The free energy for all simulations was calculated using GROMACS files. Input files were generated by selecting Poisson-Boltzmann (PB) and Generalized Born (GB) calculations. Subsequently, Van der Waals, Electrostatic, Desolvation, and Total interaction energies were computed for each system<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. The calculated interaction affinities of the protein-peptide systems are summarized in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h5 class="obj_head">Table 1.</h5>
<div class="caption p"><p>gmx_MMPBSA interaction energy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">System</th>
<th align="left" colspan="1" rowspan="1">Total interaction</th>
<th align="left" colspan="1" rowspan="1">Van der Waals</th>
<th align="left" colspan="1" rowspan="1">Electrostatic</th>
<th align="left" colspan="1" rowspan="1">Desolvation</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="5" rowspan="1">Energy (KJ/mol)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P1</td>
<td align="left" colspan="1" rowspan="1">− 105.42</td>
<td align="left" colspan="1" rowspan="1">− 50.54</td>
<td align="left" colspan="1" rowspan="1">− 54.88</td>
<td align="left" colspan="1" rowspan="1">62.99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P2</td>
<td align="left" colspan="1" rowspan="1">− 110.35</td>
<td align="left" colspan="1" rowspan="1">− 48.86</td>
<td align="left" colspan="1" rowspan="1">− 61.49</td>
<td align="left" colspan="1" rowspan="1">69.43</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P3</td>
<td align="left" colspan="1" rowspan="1">− 126.53</td>
<td align="left" colspan="1" rowspan="1">− 50.56</td>
<td align="left" colspan="1" rowspan="1">− 75.97</td>
<td align="left" colspan="1" rowspan="1">78.99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P4</td>
<td align="left" colspan="1" rowspan="1">− 82.63</td>
<td align="left" colspan="1" rowspan="1">− 39.17</td>
<td align="left" colspan="1" rowspan="1">− 43.46</td>
<td align="left" colspan="1" rowspan="1">47.84</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P5</td>
<td align="left" colspan="1" rowspan="1">− 102.92</td>
<td align="left" colspan="1" rowspan="1">− 36.91</td>
<td align="left" colspan="1" rowspan="1">− 66.01</td>
<td align="left" colspan="1" rowspan="1">72.96</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Survivin-P6</td>
<td align="left" colspan="1" rowspan="1">− 104.84</td>
<td align="left" colspan="1" rowspan="1">− 52.41</td>
<td align="left" colspan="1" rowspan="1">− 52.43</td>
<td align="left" colspan="1" rowspan="1">60.38</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p20"><p>According to the gmx_MMPBSA analysis, the table shows that the P2 and P3 peptides have the highest binding affinity to the survivin protein compared to the P1 (no mutant) peptide. The values represent averages from 80 to 100 ns during the MD simulation.</p></div></div></section></section></section><section id="Sec10"><h3 class="pmc_sec_title">Experimental</h3>
<section id="Sec11"><h4 class="pmc_sec_title">MTT assay</h4>
<p id="Par9">Cell viability in human breast cancer cells was assessed using the MTT assay. As illustrated in the diagrams (Fig. <a href="#Fig5" class="usa-link">5</a>a–e) and Table <a href="#Tab2" class="usa-link">2</a>, MCF-7 cells were treated with the anti-cancer peptide (P3) at ten different concentrations and incubated for 24 and 48 h. The antiproliferative effects of the anti-cancer peptide(P3) were measured using an ELISA reader. The results showed a significant reduction in cell viability and growth compared to the control groups.</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/9ca87d8aa598/41598_2025_13110_Fig5_HTML.jpg" loading="lazy" id="d33e786" height="641" width="677" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MTT assay. Assessment of the impact of serial dilutions of peptide on MCF-7 cells’ proliferation and viability. (<strong>a</strong>) The data shown in the diagram represent the means of independent experiments conducted at 24 h (gray column) and 48 h (black column), with error bars indicating the standard deviation. (<strong>b</strong>) MTT line graph at 24 h. (<strong>c</strong>) MTT line graph at 48 h. (<strong>d</strong>) MTT line graph showing cell viability across different concentrations. (<strong>e</strong>) MTT bar graph comparing viability at 24 and 48 h. The IC<sub>50</sub> values for both 24 and 48 h are marked with stars on the graphs. Each concentration was analyzed in triplicate. The data are expressed as the mean ± standard deviation (s.d.) of data from triplicate wells.*<em>P</em> &lt; 0.05.</p></figcaption></figure><section class="tw xbox font-sm" id="Tab2"><h5 class="obj_head">Table 2.</h5>
<div class="caption p"><p>MTT assay.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Repeat1(OD)</th>
<th align="left" colspan="1" rowspan="1">Repeat2(OD)</th>
<th align="left" colspan="1" rowspan="1">Repeat3(OD)</th>
<th align="left" colspan="1" rowspan="1">Average</th>
<th align="left" colspan="1" rowspan="1">Cell viability (%)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="7" rowspan="1">(a) Groups of 24 h treatment</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Control</td>
<td align="left" colspan="1" rowspan="1">0.836</td>
<td align="left" colspan="1" rowspan="1">0.756</td>
<td align="left" colspan="1" rowspan="1">0.759</td>
<td align="left" colspan="1" rowspan="1">0.783667</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">1.0000000000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 5µM</td>
<td align="left" colspan="1" rowspan="1">0.667</td>
<td align="left" colspan="1" rowspan="1">0.767</td>
<td align="left" colspan="1" rowspan="1">0.867</td>
<td align="left" colspan="1" rowspan="1">0.767</td>
<td align="left" colspan="1" rowspan="1">97.8732</td>
<td align="left" colspan="1" rowspan="1">0.8108325911</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 10µM</td>
<td align="left" colspan="1" rowspan="1">0.66</td>
<td align="left" colspan="1" rowspan="1">0.763</td>
<td align="left" colspan="1" rowspan="1">0.86</td>
<td align="left" colspan="1" rowspan="1">0.761</td>
<td align="left" colspan="1" rowspan="1">97.10757</td>
<td align="left" colspan="1" rowspan="1">0.7460352250</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 15µM</td>
<td align="left" colspan="1" rowspan="1">0.702</td>
<td align="left" colspan="1" rowspan="1">0.798</td>
<td align="left" colspan="1" rowspan="1">0.684</td>
<td align="left" colspan="1" rowspan="1">0.728</td>
<td align="left" colspan="1" rowspan="1">92.8966</td>
<td align="left" colspan="1" rowspan="1">0.2800540784</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 20µM</td>
<td align="left" colspan="1" rowspan="1">0.748</td>
<td align="left" colspan="1" rowspan="1">0.761</td>
<td align="left" colspan="1" rowspan="1">0.685</td>
<td align="left" colspan="1" rowspan="1">0.731333</td>
<td align="left" colspan="1" rowspan="1">93.32195</td>
<td align="left" colspan="1" rowspan="1">0.2116829747</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 25µM</td>
<td align="left" colspan="1" rowspan="1">0.64</td>
<td align="left" colspan="1" rowspan="1">0.682</td>
<td align="left" colspan="1" rowspan="1">0.701</td>
<td align="left" colspan="1" rowspan="1">0.674333</td>
<td align="left" colspan="1" rowspan="1">86.04845</td>
<td align="left" colspan="1" rowspan="1">0.0317761062</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 30µM</td>
<td align="left" colspan="1" rowspan="1">0.558</td>
<td align="left" colspan="1" rowspan="1">0.532</td>
<td align="left" colspan="1" rowspan="1">0.512</td>
<td align="left" colspan="1" rowspan="1">0.534</td>
<td align="left" colspan="1" rowspan="1">68.14119</td>
<td align="left" colspan="1" rowspan="1">0.0035528331</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 35µM</td>
<td align="left" colspan="1" rowspan="1">0.621</td>
<td align="left" colspan="1" rowspan="1">0.601</td>
<td align="left" colspan="1" rowspan="1">0.555</td>
<td align="left" colspan="1" rowspan="1">0.592333</td>
<td align="left" colspan="1" rowspan="1">75.58483</td>
<td align="left" colspan="1" rowspan="1">0.0053886617</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 40µM</td>
<td align="left" colspan="1" rowspan="1">0.416</td>
<td align="left" colspan="1" rowspan="1">0.403</td>
<td align="left" colspan="1" rowspan="1">0.359</td>
<td align="left" colspan="1" rowspan="1">0.392667</td>
<td align="left" colspan="1" rowspan="1">50.10632</td>
<td align="left" colspan="1" rowspan="1">0.0016626770</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 45µM</td>
<td align="left" colspan="1" rowspan="1">0.218</td>
<td align="left" colspan="1" rowspan="1">0.211</td>
<td align="left" colspan="1" rowspan="1">0.1645</td>
<td align="left" colspan="1" rowspan="1">0.197833</td>
<td align="left" colspan="1" rowspan="1">25.24457</td>
<td align="left" colspan="1" rowspan="1">0.0001450756</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 50µM</td>
<td align="left" colspan="1" rowspan="1">0.2676</td>
<td align="left" colspan="1" rowspan="1">0.25</td>
<td align="left" colspan="1" rowspan="1">0.24</td>
<td align="left" colspan="1" rowspan="1">0.252533</td>
<td align="left" colspan="1" rowspan="1">32.22457</td>
<td align="left" colspan="1" rowspan="1">0.0011321950</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">(b) Groups of 48 h treatment</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Control</td>
<td align="left" colspan="1" rowspan="1">0.851</td>
<td align="left" colspan="1" rowspan="1">0.884</td>
<td align="left" colspan="1" rowspan="1">0.901</td>
<td align="left" colspan="1" rowspan="1">0.878667</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">1.000000e+00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 5µM</td>
<td align="left" colspan="1" rowspan="1">0.759</td>
<td align="left" colspan="1" rowspan="1">0.739</td>
<td align="left" colspan="1" rowspan="1">0.763</td>
<td align="left" colspan="1" rowspan="1">0.753667</td>
<td align="left" colspan="1" rowspan="1">85.77357</td>
<td align="left" colspan="1" rowspan="1">4.951786e−03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 10µM</td>
<td align="left" colspan="1" rowspan="1">0.409</td>
<td align="left" colspan="1" rowspan="1">0.456</td>
<td align="left" colspan="1" rowspan="1">0.44</td>
<td align="left" colspan="1" rowspan="1">0.435</td>
<td align="left" colspan="1" rowspan="1">49.50664</td>
<td align="left" colspan="1" rowspan="1">2.593728e−05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 15µM</td>
<td align="left" colspan="1" rowspan="1">0.592</td>
<td align="left" colspan="1" rowspan="1">0.607</td>
<td align="left" colspan="1" rowspan="1">0.612</td>
<td align="left" colspan="1" rowspan="1">0.603667</td>
<td align="left" colspan="1" rowspan="1">68.70232</td>
<td align="left" colspan="1" rowspan="1">8.351517e−04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 20µM</td>
<td align="left" colspan="1" rowspan="1">0.539</td>
<td align="left" colspan="1" rowspan="1">0.412</td>
<td align="left" colspan="1" rowspan="1">0.483</td>
<td align="left" colspan="1" rowspan="1">0.478</td>
<td align="left" colspan="1" rowspan="1">54.4004</td>
<td align="left" colspan="1" rowspan="1">3.574397e−03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 25µM</td>
<td align="left" colspan="1" rowspan="1">0.41</td>
<td align="left" colspan="1" rowspan="1">0.432</td>
<td align="left" colspan="1" rowspan="1">0.476</td>
<td align="left" colspan="1" rowspan="1">0.439333</td>
<td align="left" colspan="1" rowspan="1">49.99981</td>
<td align="left" colspan="1" rowspan="1">9.184224e−05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 30µM</td>
<td align="left" colspan="1" rowspan="1">0.618</td>
<td align="left" colspan="1" rowspan="1">0.671</td>
<td align="left" colspan="1" rowspan="1">0.659</td>
<td align="left" colspan="1" rowspan="1">0.649333</td>
<td align="left" colspan="1" rowspan="1">73.89957</td>
<td align="left" colspan="1" rowspan="1">4.763872e−04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 35µM</td>
<td align="left" colspan="1" rowspan="1">0.715</td>
<td align="left" colspan="1" rowspan="1">0.665</td>
<td align="left" colspan="1" rowspan="1">0.709</td>
<td align="left" colspan="1" rowspan="1">0.696333</td>
<td align="left" colspan="1" rowspan="1">79.24856</td>
<td align="left" colspan="1" rowspan="1">1.090926e−03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 40µM</td>
<td align="left" colspan="1" rowspan="1">0.396</td>
<td align="left" colspan="1" rowspan="1">0.265</td>
<td align="left" colspan="1" rowspan="1">0.347</td>
<td align="left" colspan="1" rowspan="1">0.336</td>
<td align="left" colspan="1" rowspan="1">38.23961</td>
<td align="left" colspan="1" rowspan="1">1.930204e−03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 45µM</td>
<td align="left" colspan="1" rowspan="1">0.327</td>
<td align="left" colspan="1" rowspan="1">0.382</td>
<td align="left" colspan="1" rowspan="1">0.363</td>
<td align="left" colspan="1" rowspan="1">0.357333</td>
<td align="left" colspan="1" rowspan="1">40.66752</td>
<td align="left" colspan="1" rowspan="1">1.954061e−05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 50µM</td>
<td align="left" colspan="1" rowspan="1">0.175</td>
<td align="left" colspan="1" rowspan="1">0.362</td>
<td align="left" colspan="1" rowspan="1">0.273</td>
<td align="left" colspan="1" rowspan="1">0.27</td>
<td align="left" colspan="1" rowspan="1">30.72826</td>
<td align="left" colspan="1" rowspan="1">5.060745e−03</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p26">
<p>(a) absorbance values, percentage viability, and p-values for each concentration at 24 h.</p>
<p>(b) absorbance values, percentage viability, and p-values for each concentration at 48 h.</p>
<p>Each concentration was analyzed in triplicate.</p>
</div></div></section></section><section id="Sec12"><h4 class="pmc_sec_title">Flow cytometry apoptosis</h4>
<p id="Par10">Based on the results of the MTT analysis, the IC<sub>50</sub> concentrations were determined to be 40 μM at 24 h and 25 μM at 48 h. Therefore, these two concentrations of the medicinal peptide were used for the tests.</p>
<p id="Par11">To ascertain whether the peptide-induced growth inhibition in MCF-7 cells corresponded with the induction of apoptotic cell death, the apoptosis index was measured using the Annexin V-FITC/PI co-staining assay. According to this method, MCF-7 cells were examined by flow cytometry 24 h (40 µM) and 48 h (25 µM) post-treatment with the anti-cancer peptide (P3). Untreated MCF-7 cells served as the negative control. All data were analyzed using the dedicated software, FlowJo V10.10. The data for 24 h (Fig. <a href="#Fig6" class="usa-link">6</a>a–c) and 48 h (Fig. <a href="#Fig6" class="usa-link">6</a>d–f) are presented in diagrams. indicate that the apoptotic fraction of MCF-7 cells, as measured by flow cytometry, exceeded 80% at a concentration of 25 μM after 48 h.</p>
<figure class="fig xbox font-sm" id="Fig6"><h5 class="obj_head">Fig. 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/ebedcb4446e6/41598_2025_13110_Fig6_HTML.jpg" loading="lazy" id="d33e1216" height="925" width="794" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Apoptosis flow cytometry. Flow cytometry observations and measurements at 24 h for the treated group indicated a small percentage of apoptotic cells. (<strong>a</strong>) Control cells after 24 h of incubation. (<strong>b</strong>) treated cells after 24 h at 40 µM incubation. At 48 h, a significant increase in apoptosis was observed compared to the control group. (<strong>c</strong>) Control cells after 48 h of incubation. (<strong>d</strong>) treated cells after 48 h at 25 µM incubation. Q1:Necrosis, Q2: Late Apoptosis, Q3: Early Apoptosis, Q4: Live Cells (<strong>e</strong>) A line graph illustrating the apoptosis assessment of the treated groups compared to controls after 24 h of incubation. (<strong>f</strong>) A line graph illustrating the apoptosis assessment of the treated groups compared to controls after 48 h of incubation. The data are expressed as the mean ± standard deviation (s.d.) of data from triplicate wells. *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.001, and ***<em>P</em> &lt; 0.0001.</p></figcaption></figure></section><section id="Sec13"><h4 class="pmc_sec_title">Cell cycle analysis</h4>
<p id="Par12">In this study, the DNA content of MCF-7 cells was measured during the cell cycle to gather information about cell cycle progression. Bioinformatic analysis revealed that the peptide induces cell cycle arrest from the G2 to M phase. Therefore, the peptide’s effect on halting the MCF-7 cell cycle was investigated.</p>
<p id="Par13">The curves illustrate the distribution of DNA content across the cell cycle phases in MCF-7 cells following 24-h (Fig. <a href="#Fig7" class="usa-link">7</a>a–c) and 48-h (Fig. <a href="#Fig7" class="usa-link">7</a>d–f) treatments. In control samples (untreated MCF-7 cells), 35.08% of cells remained in the G0/G1 phase at 24 h and 39.53% at 48 h, 45.27% in the S phase at 24 h and 41.82% at 48 h, and 18.83% in the G2/M phase at 24 h and 21.17% at 48 h. Treatment of MCF-7 cells with the anti-cancer peptide (P3) at a concentration of 40 µM for 24 h and 25 µM for 48 h increased the proportion of cells in the G0/G1 phase, suggesting enhanced apoptosis. Additionally, a significant arrest of cells was observed in the G2/M phase.</p>
<figure class="fig xbox font-sm" id="Fig7"><h5 class="obj_head">Fig. 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/3557ebb63617/41598_2025_13110_Fig7_HTML.jpg" loading="lazy" id="d33e1267" height="738" width="794" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cell cycle flow cytometry, Curves estimate the percentages of MCF-7 cell populations in different cell cycle phases. (<strong>a</strong>) Control cells after 24 h of incubation. (<strong>b</strong>) treated cells after 24 h at 40 µM incubation. (<strong>c</strong>) Control cells after 48 h of incubation. (<strong>d</strong>) treated cells after 48 h at 25 µM incubation. (<strong>e</strong>) A line graph illustrating the cell cycle assessment of the treated groups compared to controls after 24 h of incubation. (<strong>f</strong>) A line graph illustrating the cell cycle assessment of the treated groups compared to controls after 48 h of incubation. The data are expressed as the mean ± standard deviation (s.d.) of data from triplicate wells. *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.001, and ***<em>P</em> &lt; 0.0001.</p></figcaption></figure></section><section id="Sec14"><h4 class="pmc_sec_title">Live/dead staining</h4>
<p id="Par14">Using fluorescence microscopy, the viability of<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>cells was assessed by labeling and quantifying both live and dead cell populations. Cells exhibiting intact membranes displayed green fluorescence, signifying viability, whereas cells with compromised membranes or those that were non-viable emitted orange and red fluorescence, respectively. Treatment with the anti-cancer peptide (P3) agent significantly increased the proportion of non-viable cells compared to the control group (Fig. <a href="#Fig8" class="usa-link">8</a>a–e). These findings suggest that the P3 promotes apoptosis in MCF-7 cells.</p>
<figure class="fig xbox font-sm" id="Fig8"><h5 class="obj_head">Fig. 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368056_41598_2025_13110_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5440/12368056/014fed138e2c/41598_2025_13110_Fig8_HTML.jpg" loading="lazy" id="d33e1314" height="621" width="677" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Live/Dead Cell Double Staining, viable and dead cells were evaluated using acridine orange/propidium iodide dual staining in MCF-7 cells. Each concentration was analyzed in triplicate. (<strong>a</strong>) Control cells after 24 h of incubation. (<strong>b</strong>) Control cells after 48 h of incubation. Not-viable cells were noticeable at 24 and 48 h in the anti-cancer peptide(P3) treated groups. (<strong>c</strong>) Treated cells after 24 h at 40 µM incubation. (<strong>d</strong>) Treated cells after 48 h at 25 µM incubation. Scale bar, 20 µm. Magnification, × 200. Green and red/orange fluorescence shows viable and non-viable cells, respectively. (<strong>e</strong>) A line graph illustrating the Live/Dead assessment (AO/PI Double Staining) of the studied groups. The data are expressed as the mean ± standard deviation (s.d.) of data from triplicate wells. *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.001, and ***<em>P</em> &lt; 0.0001.</p></figcaption></figure></section></section></section><section id="Sec15"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par15">Protein–protein interactions (PPIs) are fundamental to various biological processes and provide essential insights into protein function<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>, assembly, and communication. Disruption of Survivin’s interactions with other proteins, especially given its overexpression in cancer cells, is considered a promising approach for cancer diagnosis and treatment<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>,<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>. Peptides have emerged as a notable class of drugs with diverse applications, spanning antitumor, antidiabetic, antimicrobial, and other properties<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>,<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>–<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>. The therapeutic potential of peptides represents a rapidly advancing field of research<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>, offering several advantages, notably fewer side effects compared to small molecules<sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>,<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>. Here, we designed and identified anticancer peptides using LigPlot + version 2.2, NCC-Finder, YASARA version 22.5.22, ChimeraX version 1.7, GROMACS version 2023, and gmx_MMPBSA version 1.6.2. Previous experimental studies have demonstrated that peptide function is strongly correlated with the stability of secondary structures, such as α-helix or β-strand content, and with protein binding affinity. We utilized the structural stability of the Borealin protein as a foundation for peptide design.. Eventually, six candidate peptides were designed using NCC-Finder, LigPlot + version 2.2, and YASARA version 22.5.22. After the molecular dynamics simulation, interaction energy calculation, and RMSD analysis of all five designed protein-peptide systems compared to the Native Survivi-P1 system, it was evident that the mutating positions 71 to valine and 69 to glutamine yielded enhanced variants. Their performance surpassed that of the native (unmutated) P1 peptide. that of the Native peptide (P1) (no mutant). Transfection experiments, exposing MCF-7 cells to the peptide P3 for 4 h, indicate that the cell-penetrating sequence at the peptide’s N-terminal enhances internalization<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>–<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a></sup>. Based on the results, peptide (P3) effectively competes with Borealin for Survivin binding, inhibiting CPC formation and suppressing cancer cell division. P3 blocks Survivin’s intraction with CRM1,therby interfering with its nuclear-cytoplasmic transport. This reduces XIAP protection, weakness anti apoptotic defenses in the cytosol and ultimately leads to apoptosis. Future studies should explore Survivin’s role in stabilizing other IAPs. Blocking Survivin’s nuclear export signal (NES) impacts the localization and function of CPC components<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Consistent results across MD simulations, gmx_MMPBSA analysis, and experimental data support the clinical potential of these peptides in cancer treatment. In MTT analysis, IC<sub>50</sub><sup><a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup> values were achieved at 40 µM and 25 μM concentrations over 24 and 48 h, respectively. Flow cytometry revealed 86.6% apoptosis at 25 µM after 48 h. Cell cycle arrest in the G2/M phase was observed, demonstrating inhibition of uncontrolled proliferation. Inducing apoptosis inhibits tumor progression, metastasis, and angiogenesis. These findings suggest that peptide-based drugs may improve patient outcomes, as chemical therapies often cause nonspecific toxicity, drug resistance, and damage to healthy tissues. In contrast, peptides show lower toxicity, reduced resistance, and longer-term therapeutic viability. Although, in this study we employed advanced bioinformatics tools , including simulations and docking, to design, screen, and optimizepeptides prior to laboratory validations<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>, Comprehensive evaluation of off-target toxicity and long-term biocompatibility remains essential. Peptides, while generally less stable and prone to rapid degradation, penetrate tissue more efficiently than small molecules<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>,<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>. Still, effective delivery systems remain a challenge. Nanoliposomes are promising vehicles for targeted delivery due to their ability to encapsulate both hydrophilic and hydrophobic drugs, protect peptides from enzymatic breakdown, and prolong systemic circulation. To further enhance the systemic delivery and stability of anticancer peptides, future studies should explore advanced encapsulation strategies such as liposomal nanocarriers. Nanoliposomes present a versatile and biocompatible platform for targeted peptide delivery, offering protection against enzymatic degradation and enabling sustained drug release. Moreover, surface modifications, such as PEGylation or conjugation with tumor-specific ligands, could optimize biodistribution, minimize off-target effects, and enhance therapeutic efficacy<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>–<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>. Integrating these nanocarrier technologies with peptide-based treatments may significantly improve pharmacokinetics and clinical performance. As such, the development of liposome-based delivery systems should be considered a promising direction in the advancement of peptide therapeutics for cancer. Peptide P3 can also be conjugated with cargo molecules or chemotherapy agents via linkers, creating multifunctional therapeutic compounds<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>,<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>. This approaches enhances tereatment precision and minimizes the side effects of traditional chemotheraphy. Animal studies and biophysical assays are essential for validating in vivo efficacy. Our designed peptide stands out as a versatile and potent cancer therapeutic, capable of disrupting critical cellular pathways. Specifically, the peptide inhibits the CPC complex, halting cell division, while concurrently targeting XIAP–Survivin interactions to trigger apoptosis. By blocking Survivin’s nuclear role, the peptide combines the strengths of Sur-X derivatives with mitotic disruption, indicating superior performance<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. Moreover, freeing the Smac/DIABLO binding site boosts the effectiveness of Smac mimetics<sup><a href="#CR64" class="usa-link" aria-describedby="CR64">64</a></sup>. Structurally, the peptide exceeds small molecules like YM155 in cell permeability and tissue penetration<sup><a href="#CR65" class="usa-link" aria-describedby="CR65">65</a></sup>, allowing effective activity at lower doses and reducing off-target toxicity and resistance<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. In conclusion, the Borealin-derived anticancer peptide P3 exemplifies a novel class of rationally engineered biotherapeutics that disrupt critical molecular interactions within cancer cells. Its dual functionality, hindering mitotic progression and promoting apoptosis, positions it as a compelling candidate for next-generation cancer treatments, especially in cases resistant to conventional chemotherapies.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec17"><h3 class="pmc_sec_title">Computational</h3>
<section id="Sec18"><h4 class="pmc_sec_title">Designing, modeling, and MD simulation of peptides</h4>
<p id="Par16">The initial step in designing an inhibitory peptide for the Survivin protein involves identifying the residues responsible for the interaction between Survivin and Borealin within the CPC complex, as well as those involved in the Survivin linker. To determine the exact binding sites of Survivin in the CPC complex with Borealin and its dimeric form, the 3D structures of the CPC complex (PDB ID: 2QFA) and the Survivin dimer (PDB ID: 1E31) were utilized as templates. The NCCFinder and LigPlot + version 2.2<sup><a href="#CR66" class="usa-link" aria-describedby="CR66">66</a></sup> software (available at <a href="https://www.ebi.ac.uk/thornton-srv/software/LigPlus/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ebi.ac.uk/thornton-srv/software/LigPlus/</a>) were employed to pinpoint these binding sites. Based on this analysis, an 11-residue fragment of the Borealin protein (residues 65–75), which interacts with Survivin, was identified as a potential anticancer peptide and named P1.</p></section><section id="Sec19"><h4 class="pmc_sec_title">Peptide mutation</h4>
<p id="Par17">The FoldX plugin, version 4 (available at <a href="https://foldxsuite.crg.eu/pluginInstall" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://foldxsuite.crg.eu/pluginInstall</a>) of the YASARA software version 22.5.22 (available at <a href="https://www.yasara.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.yasara.org/</a>) was employed to introduce effective mutations in peptides<sup><a href="#CR67" class="usa-link" aria-describedby="CR67">67</a></sup>. In the initial step, the C chain and fragments 1–65 and 75 to the end of the B chain were removed from the CPC complex using YASARA software version 22.5.22. Subsequently, the N69Q, L71V, and Y73F mutations were introduced at residues 69, 71, and 73, respectively, using the YASARA FoldX plugin. Specifically, asparagine 69 was mutated to glutamine (N69Q), leucine 71 to valine (L71V), leucine 71 to isoleucine (L71I), and tyrosine 73 to phenylalanine (Y73F), and a double mutation of N69Q_Y73F. The mutations were named P2, P3, P4, P5, and P6, respectively (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab3"><h5 class="obj_head">Table 3.</h5>
<div class="caption p"><p>Peptide sequence. Peptide sequences, names are listed in the table.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Peptide name</th>
<th align="left" colspan="1" rowspan="1">Sequence</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">P1</td>
<td align="left" colspan="1" rowspan="1">RRR-LREMNWLDYFA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P2</td>
<td align="left" colspan="1" rowspan="1">RRR- LREMQWLDYFA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P3</td>
<td align="left" colspan="1" rowspan="1">RRR-LREMNWVDYFA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P4</td>
<td align="left" colspan="1" rowspan="1">RRR-LREMNWIDYFA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P5</td>
<td align="left" colspan="1" rowspan="1">RRR-LREMNWLDFFA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P6</td>
<td align="left" colspan="1" rowspan="1">RRR-LREMQWLDFFA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec20"><h4 class="pmc_sec_title">Molecular docking</h4>
<p id="Par18">The ClusPro server protocol established the connection between Survivin and peptides<sup><a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>–<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a></sup>. The results, ranging from zero to three cluster scores, were examined. The common residues involved in this connection were identified through LigPlot + software version 2.2.</p></section><section id="Sec21"><h4 class="pmc_sec_title">Molecular dynamics simulations</h4>
<p id="Par19">The six protein-peptide systems underwent Molecular Dynamics Simulations using GROMACS, version 2023 (available at <a href="https://www.gromacs.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.gromacs.org/</a>), with the CHARMM36 force field<sup><a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>. The systems were inserted into a cubic simulation water box using a simple point charge water model, and the water thickness in the solvation box was set to 10 Å. Counter ions (Cl and Na) were added by replacing water molecules at the most positive and negative electrical potentials to achieve a neutral simulation cell. Each electro-neutralized system underwent steepest-descent energy minimization to remove wrong contacts or clashes, followed by a two-step equilibration through NVT and NPT ensembles. All simulations were equilibrated at 300 K and 1 bar, using 100 ps in the NVT ensemble and 100 ps in the NPT ensemble, respectively<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>. Electrostatic interactions were calculated using the particle-mesh Ewald method. After the two-step equilibration, each system underwent a production MD run for 100 ns. The parameters and procedures of the MD simulation were adopted from earlier studies<sup><a href="#CR73" class="usa-link" aria-describedby="CR73">73</a></sup>. The trajectory files of each system were analyzed using the built-in modules of GROMACS. The dynamic stability of each system, including the backbone root mean squared deviation (RMSD) and radius of gyration (Rg), was analyzed through 2D plots. Protein-peptide interactions were further analyzed using gmx_MMPBSA version 1.6.2 (available at <a href="https://valdes-tresanco-ms.github.io/gmx_MMPBSA/dev/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://valdes-tresanco-ms.github.io/gmx_MMPBSA/dev/</a>)<sup><a href="#CR74" class="usa-link" aria-describedby="CR74">74</a></sup> and GROMACS Protein–Ligand Interactions and visualized using Ligplot + version 2.2 and YASARA version 22.5.22.</p></section></section><section id="Sec22"><h3 class="pmc_sec_title">Experimental</h3>
<section id="Sec23"><h4 class="pmc_sec_title">Cell lines and culture</h4>
<p id="Par20">The MCF7 cell line, a human breast cancer cell line, was obtained from Tehran University in Tehran, Iran. MCF7 cells were cultured in DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS) (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin(Sigma-Aldrich) in a humidified atmosphere with 5% CO<sub>2</sub> at 37 °C<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a></sup>. MCF-7 cells at passage 3 (80–90% confluence) were seeded in 96-well cell culture plates one day before transfection<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>.</p></section><section id="Sec24"><h4 class="pmc_sec_title">Cell viability assay</h4>
<p id="Par21">gmx_MMPBSA analysis consistently showed that P3 exhibited stronger binding affinity than P2. Based on these comprehensive computational assessments, we prioritized P3 for synthesis and subsequent experimental validation. The anti-cancer peptide (P3) was synthesized by Shine-Gene Molecular Biotech, Inc. (Shanghai, China) with a purity of over 98%, as confirmed by HPLC, and a molecular weight of 1912 g/mol as determined by mass spectrometry. The peptide sequence includes three arginines at the N-terminus, serving as a cell-penetrating peptide (CPP) to enhance cellular uptake<sup><a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>,<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>, (Supplementary Note 1), (Supplementary Fig. 6), (Supplementary Fig. 7). To dissolve the peptide powder, a few drops of 25% acetic acid and sterile distilled water were used to achieve a concentration of 100 μM. MCF7 cells (2 × 10<sup>4</sup> cells/mL) were seeded individually in 96-well plates and incubated for 24 h until they adhered to the plate surface. The cells were incubated in a serum-free medium for 6 h. They were then treated with the anti-cancer peptide (P3) at ten concentrations: 5 μM, 10 μM, 15 μM, 20 μM, 25 μM, 30 μM, 35 μM, 40 μM, 45 μM, and 50 μM and incubated for 4 h in serum-free DMEM for transfection experiments<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. Following transfection, the medium was replaced with DMEM containing 10% FBS, and the cells were incubated for an additional 24 and 48 h. The anti-proliferative effect of the anti-cancer peptide was evaluated using the MTT assay at both 24 and 48 h. Briefly, 20 µL of MTT solution (5 mg/mL) (Sigma-Aldrich) was added to each well, and the cells were incubated in the dark at 37 °C for 4 h. The formazan product was then dissolved in 100 µL of 10% sodium dodecyl sulfate (Sigma-Aldrich) containing 15 mM hydrochloric acid. Color intensity was measured using a microplate reader at a test and reference wavelength of 570 nm<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>.</p></section><section id="Sec25"><h4 class="pmc_sec_title">Apoptosis flowcytometry</h4>
<p id="Par22">A suspension of MCF7 cells (5 × 10<sup>5</sup> cells/mL) was seeded into four wells of a 6-well culture plate to assess the apoptotic effect of the designed anti-cancer peptide (P3) on cancer cells. Two wells were treated with different concentrations of the anti-cancer peptide (P3) (40 µM and 25 µM), while two wells were left untreated as negative controls. The cells were incubated at 37 °C in a 5% CO2 incubator for 24 and 48 h, respectively. Following incubation, the cells were detached, centrifuged at 1500 rpm for 5 min, and washed twice with phosphate-buffered saline (PBS) (Sigma-Aldrich). The cells were then resuspended in 1X binding buffer, stained with 5 µL of Annexin V-FITC (Sigma-Aldrich) and 10 µL of propidium iodide (Sigma-Aldrich)<sup><a href="#CR79" class="usa-link" aria-describedby="CR79">79</a></sup>, and fluorescence was measured using flow cytometry<sup><a href="#CR80" class="usa-link" aria-describedby="CR80">80</a></sup>. Flow cytometric analysis was conducted using FlowJo V.10.10 software(Supplementary Method 1)<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>.</p></section><section id="Sec26"><h4 class="pmc_sec_title">Cell cycle analysis</h4>
<p id="Par23">Flow cytometry was the key technique used to evaluate the DNA content during the cell cycle steps<sup><a href="#CR82" class="usa-link" aria-describedby="CR82">82</a></sup>. In brief, 5 × 10<sup>5</sup> cells/mL were treated with the anti-cancer peptide (P3) at concentrations of 40 µM and 25 µM. After 24 h (40 µM) and 48 h (25 µM), the cell pellets were washed and resuspended in 2 mL of 1% paraformaldehyde in PBS and incubated for 15 min at 4 °C. Then, the cells were centrifuged, and 1 mL of cold Perm Buffer III solution was added. The cells were incubated for 30 min at 4 °C and washed twice in PBS. Next, 500 µL of propidium iodide staining buffer (containing 50 µg/mL PI and 10 µg/mL RNase in PBS) was added and incubated for 1 h at room temperature in the dark. After staining the DNA with PI, the samples were evaluated using a flow cytometer(BD FACSCalibur, BD Biosciences, USA). Flow cytometric analysis was performed using FlowJo V.10.10 software.</p></section><section id="Sec27"><h4 class="pmc_sec_title">Live/dead cell double staining</h4>
<p id="Par24">For the Staining, MCF-7 cells (80–90% confluence) (5 × 10<sup>5</sup> cells/mL) were seeded in 24-well plates on glass slides at 37 °C, with one plate incubated for 24 h and the other for 48 h. After incubation, the cells in the control group and the treated MCF-7 cells (24 h, 40 µM, and 48 h, 25 µM) were collected and rinsed twice with PBS. The glass slides were stained with 10 µL of the prepared AO (100 µg/mL) (Sigma-Aldrich) and PI (100 µg/mL) (Sigma-Aldrich) for 15 min in the dark at 37 °C<sup><a href="#CR83" class="usa-link" aria-describedby="CR83">83</a></sup>, followed by washing with PBS three times. The stained cells were then examined under a fluorescence microscope<sup><a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>,<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a></sup> with an excitation wavelength of 488 nm and a magnification of × 200.</p></section></section></section><section id="Sec55"><h2 class="pmc_sec_title">Electronic supplementary material</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12368056/bin/41598_2025_13110_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (2.3MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors are grateful for the support of the Central Tehran Branch, Islamic Azad University, Tehran, Iran, for this work.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Hamidreza samadikhah and Seyedeh Fatemeh Ahmadi. Main manuscript text Seyedeh Fatemeh Ahmadi. Prepared figures Hamidreza samadikhah and Seyedeh Fatemeh Ahmadi and Seyed Shahriar Arab. reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes3"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par25">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Garg, H., Suri, P., Gupta, J. C., Talwar, G. P. &amp; Dubey, S. Survivin: A unique target for tumor therapy. <em>Cancer Cell Int.</em><strong>16</strong>, 49 (2016).
</cite> [<a href="https://doi.org/10.1186/s12935-016-0326-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4917988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27340370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garg,%20H.,%20Suri,%20P.,%20Gupta,%20J.%20C.,%20Talwar,%20G.%20P.%20&amp;%20Dubey,%20S.%20Survivin:%20A%20unique%20target%20for%20tumor%20therapy.%20Cancer%20Cell%20Int.16,%2049%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Jaiswal, P. K., Goel, A. &amp; Mittal, R. D. Survivin: A molecular biomarker in cancer. <em>Indian J. Med. Res.</em><strong>141</strong>(4), 389–397 (2015).
</cite> [<a href="https://doi.org/10.4103/0971-5916.159250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4510718/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26112839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jaiswal,%20P.%20K.,%20Goel,%20A.%20&amp;%20Mittal,%20R.%20D.%20Survivin:%20A%20molecular%20biomarker%20in%20cancer.%20Indian%20J.%20Med.%20Res.141(4),%20389%E2%80%93397%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Cai, X. et al. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. <em>Diagn. Pathol.</em><strong>7</strong>, 52 (2012).
</cite> [<a href="https://doi.org/10.1186/1746-1596-7-52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3487795/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22607367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cai,%20X.%20et%20al.%20Survivin%20regulates%20the%20expression%20of%20VEGF-C%20in%20lymphatic%20metastasis%20of%20breast%20cancer.%20Diagn.%20Pathol.7,%2052%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Fang, X. L. et al. Overview of role of survivin in cancer: Expression, regulation, functions, and its potential as a therapeutic target. <em>J. Drug Target.</em><strong>32</strong>(3), 223–240 (2024).
</cite> [<a href="https://doi.org/10.1080/1061186X.2024.2309563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38252514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fang,%20X.%20L.%20et%20al.%20Overview%20of%20role%20of%20survivin%20in%20cancer:%20Expression,%20regulation,%20functions,%20and%20its%20potential%20as%20a%20therapeutic%20target.%20J.%20Drug%20Target.32(3),%20223%E2%80%93240%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R. &amp; Altieri, D. C. Survivin and molecular pathogenesis of colorectal cancer. <em>Lancet</em><strong>362</strong>(9379), 205–209 (2003).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(03)13910-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12885482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim,%20P.%20J.,%20Plescia,%20J.,%20Clevers,%20H.,%20Fearon,%20E.%20R.%20&amp;%20Altieri,%20D.%20C.%20Survivin%20and%20molecular%20pathogenesis%20of%20colorectal%20cancer.%20Lancet362(9379),%20205%E2%80%93209%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Blum, B., Bar-Nur, O., Golan-Lev, T. &amp; Benvenisty, N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. <em>Nat. Biotechnol.</em><strong>27</strong>(3), 281–287 (2009).
</cite> [<a href="https://doi.org/10.1038/nbt.1527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19252483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blum,%20B.,%20Bar-Nur,%20O.,%20Golan-Lev,%20T.%20&amp;%20Benvenisty,%20N.%20The%20anti-apoptotic%20gene%20survivin%20contributes%20to%20teratoma%20formation%20by%20human%20embryonic%20stem%20cells.%20Nat.%20Biotechnol.27(3),%20281%E2%80%93287%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Siddharth, S., Das, S., Nayak, A. &amp; Kundu, C. N. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis. <em>Clin. Exp. Metastasis.</em><strong>33</strong>(7), 661–675 (2016).
</cite> [<a href="https://doi.org/10.1007/s10585-016-9809-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27411340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siddharth,%20S.,%20Das,%20S.,%20Nayak,%20A.%20&amp;%20Kundu,%20C.%20N.%20SURVIVIN%20as%20a%20marker%20for%20quiescent-breast%20cancer%20stem%20cells-An%20intermediate,%20adherent,%20pre-requisite%20phase%20of%20breast%20cancer%20metastasis.%20Clin.%20Exp.%20Metastasis.33(7),%20661%E2%80%93675%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang, Q. &amp; Greene, M. I. Survivin as a therapeutic target for the treatment of human cancer. <em>Cancers (Basel).</em><strong>16</strong>(9), 1705 (2024).
</cite> [<a href="https://doi.org/10.3390/cancers16091705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11083197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38730657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Q.%20&amp;%20Greene,%20M.%20I.%20Survivin%20as%20a%20therapeutic%20target%20for%20the%20treatment%20of%20human%20cancer.%20Cancers%20(Basel).16(9),%201705%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Berthelet, J. &amp; Dubrez, L. Regulation of apoptosis by inhibitors of apoptosis (IAPs). <em>Cells</em><strong>2</strong>(1), 163–187 (2013).
</cite> [<a href="https://doi.org/10.3390/cells2010163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3972657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24709650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berthelet,%20J.%20&amp;%20Dubrez,%20L.%20Regulation%20of%20apoptosis%20by%20inhibitors%20of%20apoptosis%20(IAPs).%20Cells2(1),%20163%E2%80%93187%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Zafari, P., Rafiei, A., Esmaeili, S. A., Moonesi, M. &amp; Taghadosi, M. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. <em>J. Cell Physiol.</em><strong>234</strong>(12), 21575–21587 (2019).
</cite> [<a href="https://doi.org/10.1002/jcp.28784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31062383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zafari,%20P.,%20Rafiei,%20A.,%20Esmaeili,%20S.%20A.,%20Moonesi,%20M.%20&amp;%20Taghadosi,%20M.%20Survivin%20a%20pivotal%20antiapoptotic%20protein%20in%20rheumatoid%20arthritis.%20J.%20Cell%20Physiol.234(12),%2021575%E2%80%9321587%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Shomali, N. et al. Survivin: A novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis. <em>Gene</em><strong>844</strong>, 146829 (2022).
</cite> [<a href="https://doi.org/10.1016/j.gene.2022.146829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35995118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shomali,%20N.%20et%20al.%20Survivin:%20A%20novel%20therapeutic%20target%20that%20correlates%20with%20survival%20of%20autoreactive%20T%20lymphocytes%20obtained%20from%20patients%20with%20ankylosing%20spondylitis.%20Gene844,%20146829%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Fernández, J. G. et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription. <em>Mol. Cancer</em><strong>13</strong>(1), 209 (2014).
</cite> [<a href="https://doi.org/10.1186/1476-4598-13-209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4177250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25204429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fern%C3%A1ndez,%20J.%20G.%20et%20al.%20Survivin%20expression%20promotes%20VEGF-induced%20tumor%20angiogenesis%20via%20PI3K/Akt%20enhanced%20%CE%B2-catenin/Tcf-Lef%20dependent%20transcription.%20Mol.%20Cancer13(1),%20209%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Verdecia, M. A. et al. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. <em>Nat. Struct. Biol.</em><strong>7</strong>(7), 602–608 (2000).
</cite> [<a href="https://doi.org/10.1038/76838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10876248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verdecia,%20M.%20A.%20et%20al.%20Structure%20of%20the%20human%20anti-apoptotic%20protein%20survivin%20reveals%20a%20dimeric%20arrangement.%20Nat.%20Struct.%20Biol.7(7),%20602%E2%80%93608%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Singh, R., Letai, A. &amp; Sarosiek, K. Regulation of apoptosis in health and disease: The balancing act of BCL-2 family proteins. <em>Nat. Rev. Mol. Cell Biol.</em><strong>20</strong>(3), 175–193 (2019).
</cite> [<a href="https://doi.org/10.1038/s41580-018-0089-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7325303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30655609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh,%20R.,%20Letai,%20A.%20&amp;%20Sarosiek,%20K.%20Regulation%20of%20apoptosis%20in%20health%20and%20disease:%20The%20balancing%20act%20of%20BCL-2%20family%20proteins.%20Nat.%20Rev.%20Mol.%20Cell%20Biol.20(3),%20175%E2%80%93193%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Barzegar Behrooz, A., Talaie, Z., Jusheghani, F., Łos, M. J., Klonisch, T. &amp; Ghavami, S. Wnt and PI3K/Akt/mTOR survival pathways as therapeutic targets in glioblastoma. <em>Int. J. Mol. Sci.</em><strong>23</strong>(3), (2022).</cite> [<a href="https://doi.org/10.3390/ijms23031353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8836096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35163279/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Bu, H., Liu, D., Cui, J., Cai, K. &amp; Shen, F. Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells. <em>Transl. Cancer Res.</em><strong>8</strong>(5), 1782–1794 (2019).
</cite> [<a href="https://doi.org/10.21037/tcr.2019.08.25" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8797304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35116929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bu,%20H.,%20Liu,%20D.,%20Cui,%20J.,%20Cai,%20K.%20&amp;%20Shen,%20F.%20Wnt/%CE%B2-catenin%20signaling%20pathway%20is%20involved%20in%20induction%20of%20apoptosis%20by%20oridonin%20in%20colon%20cancer%20COLO205%20cells.%20Transl.%20Cancer%20Res.8(5),%201782%E2%80%931794%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Fang, W. et al. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex. <em>J. Exp. Clin. Cancer Res.</em><strong>39</strong>(1), 82 (2020).
</cite> [<a href="https://doi.org/10.1186/s13046-020-01581-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7203900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32381104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fang,%20W.%20et%20al.%20Sur-X,%20a%20novel%20peptide,%20kills%20colorectal%20cancer%20cells%20by%20targeting%20survivin-XIAP%20complex.%20J.%20Exp.%20Clin.%20Cancer%20Res.39(1),%2082%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>de Souza, T. L. et al. Conformational selection, dynamic restriction and the hydrophobic effect coupled to stabilization of the BIR3 domain of the human X-linked inhibitor of apoptosis protein by the tetrapeptide AVPI. <em>Biophys. Chem.</em><strong>152</strong>(1–3), 99–108 (2010).
</cite> [<a href="https://doi.org/10.1016/j.bpc.2010.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20843595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Souza,%20T.%20L.%20et%20al.%20Conformational%20selection,%20dynamic%20restriction%20and%20the%20hydrophobic%20effect%20coupled%20to%20stabilization%20of%20the%20BIR3%20domain%20of%20the%20human%20X-linked%20inhibitor%20of%20apoptosis%20protein%20by%20the%20tetrapeptide%20AVPI.%20Biophys.%20Chem.152(1%E2%80%933),%2099%E2%80%93108%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Cheung, C. H. A., Chang, Y. C., Lin, T. Y., Cheng, S. M. &amp; Leung, E. Anti-apoptotic proteins in the autophagic world: An update on functions of XIAP, Survivin, and BRUCE. <em>J. Biomed. Sci.</em><strong>27</strong>(1), 31 (2020).
</cite> [<a href="https://doi.org/10.1186/s12929-020-0627-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7001279/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32019552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheung,%20C.%20H.%20A.,%20Chang,%20Y.%20C.,%20Lin,%20T.%20Y.,%20Cheng,%20S.%20M.%20&amp;%20Leung,%20E.%20Anti-apoptotic%20proteins%20in%20the%20autophagic%20world:%20An%20update%20on%20functions%20of%20XIAP,%20Survivin,%20and%20BRUCE.%20J.%20Biomed.%20Sci.27(1),%2031%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Sun, H. et al. Design of small-molecule peptidic and nonpeptidic Smac mimetics. <em>Acc. Chem. Res.</em><strong>41</strong>(10), 1264–1277 (2008).
</cite> [<a href="https://doi.org/10.1021/ar8000553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2676167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18937395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun,%20H.%20et%20al.%20Design%20of%20small-molecule%20peptidic%20and%20nonpeptidic%20Smac%20mimetics.%20Acc.%20Chem.%20Res.41(10),%201264%E2%80%931277%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Carneiro, B. A. &amp; El-Deiry, W. S. Targeting apoptosis in cancer therapy. <em>Nat. Rev. Clin. Oncol.</em><strong>17</strong>(7), 395–417 (2020).
</cite> [<a href="https://doi.org/10.1038/s41571-020-0341-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8211386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32203277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carneiro,%20B.%20A.%20&amp;%20El-Deiry,%20W.%20S.%20Targeting%20apoptosis%20in%20cancer%20therapy.%20Nat.%20Rev.%20Clin.%20Oncol.17(7),%20395%E2%80%93417%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Wheatley, S. P. &amp; Altieri, D. C. Survivin at a glance. <em>J. Cell Sci.</em><strong>132</strong>(7), jcs223826 (2019).
</cite> [<a href="https://doi.org/10.1242/jcs.223826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6467487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30948431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wheatley,%20S.%20P.%20&amp;%20Altieri,%20D.%20C.%20Survivin%20at%20a%20glance.%20J.%20Cell%20Sci.132(7),%20jcs223826%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Dallaglio, K., Marconi, A. &amp; Pincelli, C. Survivin: A dual player in healthy and diseased skin. <em>J. Invest. Dermatol.</em><strong>132</strong>(1), 18–27 (2012).
</cite> [<a href="https://doi.org/10.1038/jid.2011.279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21900948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dallaglio,%20K.,%20Marconi,%20A.%20&amp;%20Pincelli,%20C.%20Survivin:%20A%20dual%20player%20in%20healthy%20and%20diseased%20skin.%20J.%20Invest.%20Dermatol.132(1),%2018%E2%80%9327%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Wang, Q. &amp; Greene, M. I. Survivin as a therapeutic target for the treatment of human cancer. <em>Cancers</em><strong>16</strong>(9), 1705 (2024).
</cite> [<a href="https://doi.org/10.3390/cancers16091705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11083197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38730657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Q.%20&amp;%20Greene,%20M.%20I.%20Survivin%20as%20a%20therapeutic%20target%20for%20the%20treatment%20of%20human%20cancer.%20Cancers16(9),%201705%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Espinosa, M. et al. Survivin isoform Delta Ex3 regulates tumor spheroid formation. <em>Cancer Lett.</em><strong>318</strong>(1), 61–67 (2012).
</cite> [<a href="https://doi.org/10.1016/j.canlet.2011.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22155745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Espinosa,%20M.%20et%20al.%20Survivin%20isoform%20Delta%20Ex3%20regulates%20tumor%20spheroid%20formation.%20Cancer%20Lett.318(1),%2061%E2%80%9367%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Meiners, A. et al. Specific inhibition of the Survivin–CRM1 interaction by peptide-modified molecular tweezers. <em>Nat. Commun.</em><strong>12</strong>(1), 1505 (2021).
</cite> [<a href="https://doi.org/10.1038/s41467-021-21753-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7940618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33686072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meiners,%20A.%20et%20al.%20Specific%20inhibition%20of%20the%20Survivin%E2%80%93CRM1%20interaction%20by%20peptide-modified%20molecular%20tweezers.%20Nat.%20Commun.12(1),%201505%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Kondapuram, S. K., Ramachandran, H. K., Arya, H. &amp; Coumar, M. S. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development. <em>Life Sci.</em><strong>335</strong>, 122260 (2023).
</cite> [<a href="https://doi.org/10.1016/j.lfs.2023.122260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37963509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kondapuram,%20S.%20K.,%20Ramachandran,%20H.%20K.,%20Arya,%20H.%20&amp;%20Coumar,%20M.%20S.%20Targeting%20survivin%20for%20cancer%20therapy:%20Strategies,%20small%20molecule%20inhibitors%20and%20vaccine%20based%20therapeutics%20in%20development.%20Life%20Sci.335,%20122260%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Wang, H. et al. Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. <em>J. Biol. Chem.</em><strong>285</strong>(46), 36129–36137 (2010).
</cite> [<a href="https://doi.org/10.1074/jbc.M110.152777" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2975235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20826784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20H.%20et%20al.%20Acetylation%20directs%20survivin%20nuclear%20localization%20to%20repress%20STAT3%20oncogenic%20activity.%20J.%20Biol.%20Chem.285(46),%2036129%E2%80%9336137%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Pavlyukov, M. S. et al. Survivin monomer plays an essential role in apoptosis regulation. <em>J. Biol. Chem.</em><strong>286</strong>(26), 23296–23307 (2011).
</cite> [<a href="https://doi.org/10.1074/jbc.M111.237586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3123095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21536684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pavlyukov,%20M.%20S.%20et%20al.%20Survivin%20monomer%20plays%20an%20essential%20role%20in%20apoptosis%20regulation.%20J.%20Biol.%20Chem.286(26),%2023296%E2%80%9323307%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Hadders, M. A. &amp; Lens, S. M. A. Changing places: Chromosomal Passenger Complex relocation in early anaphase. <em>Trends Cell Biol.</em><strong>32</strong>(2), 165–176 (2022).
</cite> [<a href="https://doi.org/10.1016/j.tcb.2021.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34663523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hadders,%20M.%20A.%20&amp;%20Lens,%20S.%20M.%20A.%20Changing%20places:%20Chromosomal%20Passenger%20Complex%20relocation%20in%20early%20anaphase.%20Trends%20Cell%20Biol.32(2),%20165%E2%80%93176%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Carmena, M., Wheelock, M., Funabiki, H. &amp; Earnshaw, W. C. The chromosomal passenger complex (CPC): From easy rider to the godfather of mitosis. <em>Nat. Rev. Mol. Cell Biol.</em><strong>13</strong>(12), 789–803 (2012).
</cite> [<a href="https://doi.org/10.1038/nrm3474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3729939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23175282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carmena,%20M.,%20Wheelock,%20M.,%20Funabiki,%20H.%20&amp;%20Earnshaw,%20W.%20C.%20The%20chromosomal%20passenger%20complex%20(CPC):%20From%20easy%20rider%20to%20the%20godfather%20of%20mitosis.%20Nat.%20Rev.%20Mol.%20Cell%20Biol.13(12),%20789%E2%80%93803%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Jeyaprakash, A. A. et al. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. <em>Cell</em><strong>131</strong>(2), 271–285 (2007).
</cite> [<a href="https://doi.org/10.1016/j.cell.2007.07.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17956729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jeyaprakash,%20A.%20A.%20et%20al.%20Structure%20of%20a%20Survivin-Borealin-INCENP%20core%20complex%20reveals%20how%20chromosomal%20passengers%20travel%20together.%20Cell131(2),%20271%E2%80%93285%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Xu, Z. et al. INCENP-aurora B interactions modulate kinase activity and chromosome passenger complex localization. <em>J. Cell Biol.</em><strong>187</strong>(5), 637–653 (2009).
</cite> [<a href="https://doi.org/10.1083/jcb.200906053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2806593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19951914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu,%20Z.%20et%20al.%20INCENP-aurora%20B%20interactions%20modulate%20kinase%20activity%20and%20chromosome%20passenger%20complex%20localization.%20J.%20Cell%20Biol.187(5),%20637%E2%80%93653%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Garlapati, C. et al. PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer. <em>Cell Death Dis.</em><strong>14</strong>(1), 12 (2023).
</cite> [<a href="https://doi.org/10.1038/s41419-022-05539-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9832024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36627281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garlapati,%20C.%20et%20al.%20PLK1%20and%20AURKB%20phosphorylate%20survivin%20differentially%20to%20affect%20proliferation%20in%20racially%20distinct%20triple-negative%20breast%20cancer.%20Cell%20Death%20Dis.14(1),%2012%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Chu, Y. et al. Aurora B kinase activation requires survivin priming phosphorylation by PLK1. <em>J. Mol. Cell Biol.</em><strong>3</strong>(4), 260–267 (2011).
</cite> [<a href="https://doi.org/10.1093/jmcb/mjq037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3150119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21148584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chu,%20Y.%20et%20al.%20Aurora%20B%20kinase%20activation%20requires%20survivin%20priming%20phosphorylation%20by%20PLK1.%20J.%20Mol.%20Cell%20Biol.3(4),%20260%E2%80%93267%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Colnaghi, R. &amp; Wheatley, S. P. Liaisons between survivin and Plk1 during cell division and cell death. <em>J. Biol. Chem.</em><strong>285</strong>(29), 22592–22604 (2010).
</cite> [<a href="https://doi.org/10.1074/jbc.M109.065003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2903399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20427271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Colnaghi,%20R.%20&amp;%20Wheatley,%20S.%20P.%20Liaisons%20between%20survivin%20and%20Plk1%20during%20cell%20division%20and%20cell%20death.%20J.%20Biol.%20Chem.285(29),%2022592%E2%80%9322604%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Wheatley, S. P. &amp; McNeish. I. A. Survivin: A protein with dual roles in mitosis and apoptosis. international review of cytology. Vo. 247, pp. 35–88, (Academic Press; 2005).</cite> [<a href="https://doi.org/10.1016/S0074-7696(05)47002-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16344111/" class="usa-link">PubMed</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Nozaki, I. et al. Borealin-derived peptides as survivin-targeting cancer imaging and therapeutic agents. <em>Bioconjug. Chem.</em><strong>33</strong>(11), 2149–2160 (2022).
</cite> [<a href="https://doi.org/10.1021/acs.bioconjchem.2c00398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36317771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nozaki,%20I.%20et%20al.%20Borealin-derived%20peptides%20as%20survivin-targeting%20cancer%20imaging%20and%20therapeutic%20agents.%20Bioconjug.%20Chem.33(11),%202149%E2%80%932160%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Li, C. M. et al. Novel peptide therapeutic approaches for cancer treatment. <em>Cells</em><strong>10</strong>(11), 2908 (2021).
</cite> [<a href="https://doi.org/10.3390/cells10112908" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8616177/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34831131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20C.%20M.%20et%20al.%20Novel%20peptide%20therapeutic%20approaches%20for%20cancer%20treatment.%20Cells10(11),%202908%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Aier, I., Varadwaj, P. K. &amp; Raj, U. Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. <em>Sci. Rep.</em><strong>6</strong>, 34984 (2016).
</cite> [<a href="https://doi.org/10.1038/srep34984" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5054529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27713574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aier,%20I.,%20Varadwaj,%20P.%20K.%20&amp;%20Raj,%20U.%20Structural%20insights%20into%20conformational%20stability%20of%20both%20wild-type%20and%20mutant%20EZH2%20receptor.%20Sci.%20Rep.6,%2034984%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Ghavamipour, F. et al. Development of highly potent anti-angiogenic VEGF8–109 heterodimer by directed blocking of its VEGFR-2 binding site. <em>FEBS J.</em><strong>281</strong>, 4479–4494 (2014).
</cite> [<a href="https://doi.org/10.1111/febs.12956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25132001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghavamipour,%20F.%20et%20al.%20Development%20of%20highly%20potent%20anti-angiogenic%20VEGF8%E2%80%93109%20heterodimer%20by%20directed%20blocking%20of%20its%20VEGFR-2%20binding%20site.%20FEBS%20J.281,%204479%E2%80%934494%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Yin, H. et al. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates. <em>Bioorg. Chem.</em><strong>138</strong>, 106674 (2023).
</cite> [<a href="https://doi.org/10.1016/j.bioorg.2023.106674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37331169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin,%20H.%20et%20al.%20Design,%20synthesis%20and%20anticancer%20evaluation%20of%20novel%20oncolytic%20peptide-chlorambucil%20conjugates.%20Bioorg.%20Chem.138,%20106674%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Bendel, A. M. et al. The genetic architecture of protein interaction affinity and specificity. <em>Nat. Commun.</em><strong>15</strong>(1), 8868 (2024).
</cite> [<a href="https://doi.org/10.1038/s41467-024-53195-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11479274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39402041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bendel,%20A.%20M.%20et%20al.%20The%20genetic%20architecture%20of%20protein%20interaction%20affinity%20and%20specificity.%20Nat.%20Commun.15(1),%208868%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Zeng, M. et al. Protein–protein interaction site prediction through combining local and global features with deep neural networks. <em>Bioinformatics</em><strong>36</strong>(4), 1114–1120 (2020).
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btz699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31593229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zeng,%20M.%20et%20al.%20Protein%E2%80%93protein%20interaction%20site%20prediction%20through%20combining%20local%20and%20global%20features%20with%20deep%20neural%20networks.%20Bioinformatics36(4),%201114%E2%80%931120%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Scott, D. E., Bayly, A. R., Abell, C. &amp; Skidmore, J. Small molecules, big targets: Drug discovery faces the protein-protein interaction challenge. <em>Nat. Rev. Drug. Discov.</em><strong>15</strong>(8), 533–550 (2016).
</cite> [<a href="https://doi.org/10.1038/nrd.2016.29" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27050677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scott,%20D.%20E.,%20Bayly,%20A.%20R.,%20Abell,%20C.%20&amp;%20Skidmore,%20J.%20Small%20molecules,%20big%20targets:%20Drug%20discovery%20faces%20the%20protein-protein%20interaction%20challenge.%20Nat.%20Rev.%20Drug.%20Discov.15(8),%20533%E2%80%93550%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Mita, A. C., Mita, M. M., Nawrocki, S. T. &amp; Giles, F. J. Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. <em>Clin. Cancer Res.</em><strong>14</strong>(16), 5000–5005 (2008).
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-08-0746" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18698017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mita,%20A.%20C.,%20Mita,%20M.%20M.,%20Nawrocki,%20S.%20T.%20&amp;%20Giles,%20F.%20J.%20Survivin:%20Key%20regulator%20of%20mitosis%20and%20apoptosis%20and%20novel%20target%20for%20cancer%20therapeutics.%20Clin.%20Cancer%20Res.14(16),%205000%E2%80%935005%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Vallet, C. et al. Functional disruption of the cancer-relevant interaction between survivin and histone H3 with a guanidiniocarbonyl pyrrole ligand. <em>Angew Chem. Int. Ed. Engl.</em><strong>59</strong>(14), 5567–5571 (2020).
</cite> [<a href="https://doi.org/10.1002/anie.201915400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7155087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31916356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vallet,%20C.%20et%20al.%20Functional%20disruption%20of%20the%20cancer-relevant%20interaction%20between%20survivin%20and%20histone%20H3%20with%20a%20guanidiniocarbonyl%20pyrrole%20ligand.%20Angew%20Chem.%20Int.%20Ed.%20Engl.59(14),%205567%E2%80%935571%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Wang, L. et al. Therapeutic peptides: Current applications and future directions. <em>Signal Transduct. Target. Ther.</em><strong>7</strong>(1), 48 (2022).
</cite> [<a href="https://doi.org/10.1038/s41392-022-00904-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8844085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35165272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20L.%20et%20al.%20Therapeutic%20peptides:%20Current%20applications%20and%20future%20directions.%20Signal%20Transduct.%20Target.%20Ther.7(1),%2048%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Fu, X.-Y. et al. Three rounds of stability-guided optimization and systematical evaluation of oncolytic peptide LTX-315. <em>J. Med. Chem.</em><strong>67</strong>(5), 3885–3908 (2024).
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.3c02232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38278140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu,%20X.-Y.%20et%20al.%20Three%20rounds%20of%20stability-guided%20optimization%20and%20systematical%20evaluation%20of%20oncolytic%20peptide%20LTX-315.%20J.%20Med.%20Chem.67(5),%203885%E2%80%933908%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Yin, H. et al. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. <em>Acta Pharmacol. Sin.</em><strong>44</strong>, 201 (2023).
</cite> [<a href="https://doi.org/10.1038/s41401-022-00939-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9813345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35794372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin,%20H.%20et%20al.%20The%20hybrid%20oncolytic%20peptide%20NTP-385%20potently%20inhibits%20adherent%20cancer%20cells%20by%20targeting%20the%20nucleus.%20Acta%20Pharmacol.%20Sin.44,%20201%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Rossino, G. et al. Peptides as therapeutic agents: Challenges and opportunities in the green transition era. <em>Molecules</em><strong>28</strong>(20), 7165 (2023).
</cite> [<a href="https://doi.org/10.3390/molecules28207165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10609221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37894644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rossino,%20G.%20et%20al.%20Peptides%20as%20therapeutic%20agents:%20Challenges%20and%20opportunities%20in%20the%20green%20transition%20era.%20Molecules28(20),%207165%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Mougel, A. et al. Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling. <em>Oncoimmunology</em><strong>11</strong>(1), 2110218 (2022).
</cite> [<a href="https://doi.org/10.1080/2162402X.2022.2110218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9367646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35968405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mougel,%20A.%20et%20al.%20Synergistic%20effect%20of%20combining%20sunitinib%20with%20a%20peptide-based%20vaccine%20in%20cancer%20treatment%20after%20microenvironment%20remodeling.%20Oncoimmunology11(1),%202110218%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Schmidt, N., Mishra, A., Lai, G. H. &amp; Wong, G. C. Arginine-rich cell-penetrating peptides. <em>FEBS Lett.</em><strong>584</strong>(9), 1806–1813 (2010).
</cite> [<a href="https://doi.org/10.1016/j.febslet.2009.11.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19925791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmidt,%20N.,%20Mishra,%20A.,%20Lai,%20G.%20H.%20&amp;%20Wong,%20G.%20C.%20Arginine-rich%20cell-penetrating%20peptides.%20FEBS%20Lett.584(9),%201806%E2%80%931813%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Lunde, P. K. et al. Polyarginine cell-penetrating peptides bind and inhibit SERCA2. <em>Cells</em><strong>12</strong>(19), 2358 (2023).
</cite> [<a href="https://doi.org/10.3390/cells12192358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10571751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37830576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lunde,%20P.%20K.%20et%20al.%20Polyarginine%20cell-penetrating%20peptides%20bind%20and%20inhibit%20SERCA2.%20Cells12(19),%202358%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Madani, F., Lindberg, S., Langel, U., Futaki, S. &amp; Gräslund, A. Mechanisms of cellular uptake of cell-penetrating peptides. <em>J. Biophys.</em><strong>2011</strong>, 414729 (2011).
</cite> [<a href="https://doi.org/10.1155/2011/414729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3103903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21687343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Madani,%20F.,%20Lindberg,%20S.,%20Langel,%20U.,%20Futaki,%20S.%20&amp;%20Gr%C3%A4slund,%20A.%20Mechanisms%20of%20cellular%20uptake%20of%20cell-penetrating%20peptides.%20J.%20Biophys.2011,%20414729%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Majidi, A., Nikkhah, M., Sadeghian, F. &amp; Hosseinkhani, S. Development of novel recombinant biomimetic chimeric MPG-based peptide as nanocarriers for gene delivery: Imitation of a real cargo. <em>Eur. J. Pharm. Biopharm.</em><strong>107</strong>, 191–204 (2016).
</cite> [<a href="https://doi.org/10.1016/j.ejpb.2016.06.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27368745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Majidi,%20A.,%20Nikkhah,%20M.,%20Sadeghian,%20F.%20&amp;%20Hosseinkhani,%20S.%20Development%20of%20novel%20recombinant%20biomimetic%20chimeric%20MPG-based%20peptide%20as%20nanocarriers%20for%20gene%20delivery:%20Imitation%20of%20a%20real%20cargo.%20Eur.%20J.%20Pharm.%20Biopharm.107,%20191%E2%80%93204%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>He, Y. et al. The changing 50% inhibitory concentration (IC50) of cisplatin: A pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. <em>Oncotarget</em><strong>7</strong>(43), 70803–70821 (2016).
</cite> [<a href="https://doi.org/10.18632/oncotarget.12223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5342590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27683123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He,%20Y.%20et%20al.%20The%20changing%2050%%20inhibitory%20concentration%20(IC50)%20of%20cisplatin:%20A%20pilot%20study%20on%20the%20artifacts%20of%20the%20MTT%20assay%20and%20the%20precise%20measurement%20of%20density-dependent%20chemoresistance%20in%20ovarian%20cancer.%20Oncotarget7(43),%2070803%E2%80%9370821%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Zahraee, H., Arab, S. S., Khoshbin, Z., Taghdisi, S. M. &amp; Abnous, K. Molecular dynamics simulation as a promising approach for computational study of liquid crystal-based aptasensors. <em>J. Biomol. Struct. Dyn.</em>, 2024:1–13.</cite> [<a href="https://doi.org/10.1080/07391102.2024.2315326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38344904/" class="usa-link">PubMed</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Vadevoo, S. M. P. et al. Peptides as multifunctional players in cancer therapy. <em>Exp. Mol. Med.</em><strong>55</strong>(6), 1099–1109 (2023).
</cite> [<a href="https://doi.org/10.1038/s12276-023-01016-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10318096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37258584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vadevoo,%20S.%20M.%20P.%20et%20al.%20Peptides%20as%20multifunctional%20players%20in%20cancer%20therapy.%20Exp.%20Mol.%20Med.55(6),%201099%E2%80%931109%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Samadikhah, H. R., Majidi, A., Nikkhah, M. &amp; Hosseinkhani, S. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. <em>Int. J. Nanomed.</em><strong>6</strong>, 2275–2283 (2011).</cite> [<a href="https://doi.org/10.2147/IJN.S23074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3205124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22072865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Samadikhah,%20H.%20R.,%20Majidi,%20A.,%20Nikkhah,%20M.%20&amp;%20Hosseinkhani,%20S.%20Preparation,%20characterization,%20and%20efficient%20transfection%20of%20cationic%20liposomes%20and%20nanomagnetic%20cationic%20liposomes.%20Int.%20J.%20Nanomed.6,%202275%E2%80%932283%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Pande, S. Liposomes for drug delivery: Review of vesicular composition, factors affecting drug release and drug loading in liposomes. <em>Artificial Cells Nanomed. Biotechnol.</em><strong>51</strong>(1), 428–440 (2023).</cite> [<a href="https://doi.org/10.1080/21691401.2023.2247036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37594208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pande,%20S.%20Liposomes%20for%20drug%20delivery:%20Review%20of%20vesicular%20composition,%20factors%20affecting%20drug%20release%20and%20drug%20loading%20in%20liposomes.%20Artificial%20Cells%20Nanomed.%20Biotechnol.51(1),%20428%E2%80%93440%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Cui, J., Wen, Z., Zhang, W. &amp; Wu, W. Recent advances in oral peptide or protein-based drug liposomes. <em>Pharmaceuticals</em><strong>15</strong>(9), 1072 (2022).
</cite> [<a href="https://doi.org/10.3390/ph15091072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9501131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36145293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui,%20J.,%20Wen,%20Z.,%20Zhang,%20W.%20&amp;%20Wu,%20W.%20Recent%20advances%20in%20oral%20peptide%20or%20protein-based%20drug%20liposomes.%20Pharmaceuticals15(9),%201072%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Naeem, A., Noureen, N., Al-Naemi, S. K., Al-Emadi, J. A. &amp; Khan, M. J. Computational design of anti-cancer peptides tailored to target specific tumor markers. <em>BMC Chem.</em><strong>18</strong>(1), 39 (2024).
</cite> [<a href="https://doi.org/10.1186/s13065-024-01143-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10882887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38388460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naeem,%20A.,%20Noureen,%20N.,%20Al-Naemi,%20S.%20K.,%20Al-Emadi,%20J.%20A.%20&amp;%20Khan,%20M.%20J.%20Computational%20design%20of%20anti-cancer%20peptides%20tailored%20to%20target%20specific%20tumor%20markers.%20BMC%20Chem.18(1),%2039%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Bai, L., Smith, D. C. &amp; Wang, S. Small-molecule SMAC mimetics as new cancer therapeutics. <em>Pharmacol. Ther.</em><strong>144</strong>(1), 82–95 (2014).
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2014.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4247261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24841289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bai,%20L.,%20Smith,%20D.%20C.%20&amp;%20Wang,%20S.%20Small-molecule%20SMAC%20mimetics%20as%20new%20cancer%20therapeutics.%20Pharmacol.%20Ther.144(1),%2082%E2%80%9395%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Nakahara, T. et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. <em>Cancer Res.</em><strong>67</strong>(17), 8014–8021 (2007).
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-1343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17804712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nakahara,%20T.%20et%20al.%20YM155,%20a%20novel%20small-molecule%20survivin%20suppressant,%20induces%20regression%20of%20established%20human%20hormone-refractory%20prostate%20tumor%20xenografts.%20Cancer%20Res.67(17),%208014%E2%80%938021%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Laskowski, R. A. &amp; Swindells, M. B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. <em>J. Chem. Inf. Model.</em><strong>51</strong>(10), 2778–2786 (2011).
</cite> [<a href="https://doi.org/10.1021/ci200227u" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21919503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laskowski,%20R.%20A.%20&amp;%20Swindells,%20M.%20B.%20LigPlot+:%20Multiple%20ligand-protein%20interaction%20diagrams%20for%20drug%20discovery.%20J.%20Chem.%20Inf.%20Model.51(10),%202778%E2%80%932786%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Buß, O., Rudat, J. &amp; Ochsenreither, K. FoldX as protein engineering tool: Better than random based approaches?. <em>Comput. Struct. Biotechnol. J.</em><strong>16</strong>, 25–33 (2018).
</cite> [<a href="https://doi.org/10.1016/j.csbj.2018.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6158775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30275935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bu%C3%9F,%20O.,%20Rudat,%20J.%20&amp;%20Ochsenreither,%20K.%20FoldX%20as%20protein%20engineering%20tool:%20Better%20than%20random%20based%20approaches?.%20Comput.%20Struct.%20Biotechnol.%20J.16,%2025%E2%80%9333%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Desta, I. T. et al. The ClusPro AbEMap web server for the prediction of antibody epitopes. <em>Nat. Protoc.</em><strong>18</strong>(6), 1814–1840 (2023).
</cite> [<a href="https://doi.org/10.1038/s41596-023-00826-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10898366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37188806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Desta,%20I.%20T.%20et%20al.%20The%20ClusPro%20AbEMap%20web%20server%20for%20the%20prediction%20of%20antibody%20epitopes.%20Nat.%20Protoc.18(6),%201814%E2%80%931840%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M. &amp; Kozakov, D. Protein-protein and protein-peptide docking with ClusPro server. <em>Methods Mol. Biol.</em><strong>2165</strong>, 157–174 (2020).
</cite> [<a href="https://doi.org/10.1007/978-1-0716-0708-4_9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32621224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alekseenko,%20A.,%20Ignatov,%20M.,%20Jones,%20G.,%20Sabitova,%20M.%20&amp;%20Kozakov,%20D.%20Protein-protein%20and%20protein-peptide%20docking%20with%20ClusPro%20server.%20Methods%20Mol.%20Biol.2165,%20157%E2%80%93174%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Porter, K. A., Desta, I., Kozakov, D. &amp; Vajda, S. What method to use for protein-protein docking?. <em>Curr. Opin. Struct. Biol.</em><strong>55</strong>, 1–7 (2019).
</cite> [<a href="https://doi.org/10.1016/j.sbi.2018.12.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6669123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30711743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Porter,%20K.%20A.,%20Desta,%20I.,%20Kozakov,%20D.%20&amp;%20Vajda,%20S.%20What%20method%20to%20use%20for%20protein-protein%20docking?.%20Curr.%20Opin.%20Struct.%20Biol.55,%201%E2%80%937%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Huang, J. et al. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. <em>Nat. Methods</em><strong>14</strong>(1), 71–73 (2017).
</cite> [<a href="https://doi.org/10.1038/nmeth.4067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5199616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27819658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang,%20J.%20et%20al.%20CHARMM36m:%20An%20improved%20force%20field%20for%20folded%20and%20intrinsically%20disordered%20proteins.%20Nat.%20Methods14(1),%2071%E2%80%9373%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Kumar, V. &amp; Yaduvanshi, S. Protein-protein interaction studies using molecular dynamics simulation. <em>Methods Mol. Biol.</em><strong>2652</strong>, 269–283 (2023).
</cite> [<a href="https://doi.org/10.1007/978-1-0716-3147-8_16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37093482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumar,%20V.%20&amp;%20Yaduvanshi,%20S.%20Protein-protein%20interaction%20studies%20using%20molecular%20dynamics%20simulation.%20Methods%20Mol.%20Biol.2652,%20269%E2%80%93283%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Hollingsworth, S. A. &amp; Dror, R. O. Molecular dynamics simulation for all. <em>Neuron</em><strong>99</strong>(6), 1129–1143 (2018).
</cite> [<a href="https://doi.org/10.1016/j.neuron.2018.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6209097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30236283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hollingsworth,%20S.%20A.%20&amp;%20Dror,%20R.%20O.%20Molecular%20dynamics%20simulation%20for%20all.%20Neuron99(6),%201129%E2%80%931143%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Valdés-Tresanco, M., Valdés-Tresanco, M., Valiente, P. &amp; Moreno, F. E. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. <em>J. Chem. Theory Comput.</em><strong>17</strong>(10), 6281–6291 (2021).
</cite> [<a href="https://doi.org/10.1021/acs.jctc.1c00645" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34586825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vald%C3%A9s-Tresanco,%20M.,%20Vald%C3%A9s-Tresanco,%20M.,%20Valiente,%20P.%20&amp;%20Moreno,%20F.%20E.%20gmx_MMPBSA:%20A%20new%20tool%20to%20perform%20end-state%20free%20energy%20calculations%20with%20GROMACS.%20J.%20Chem.%20Theory%20Comput.17(10),%206281%E2%80%936291%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Muthusamy, T. et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. <em>Nature</em><strong>586</strong>(7831), 790–795 (2020).
</cite> [<a href="https://doi.org/10.1038/s41586-020-2609-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7606299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32788725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muthusamy,%20T.%20et%20al.%20Serine%20restriction%20alters%20sphingolipid%20diversity%20to%20constrain%20tumour%20growth.%20Nature586(7831),%20790%E2%80%93795%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Saw, P. E. &amp; Song, E. W. Phage display screening of therapeutic peptide for cancer targeting and therapy. <em>Protein Cell.</em><strong>10</strong>(11), 787–807 (2019).
</cite> [<a href="https://doi.org/10.1007/s13238-019-0639-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6834755/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31140150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saw,%20P.%20E.%20&amp;%20Song,%20E.%20W.%20Phage%20display%20screening%20of%20therapeutic%20peptide%20for%20cancer%20targeting%20and%20therapy.%20Protein%20Cell.10(11),%20787%E2%80%93807%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Zhou, M. et al. The role of cell-penetrating peptides in potential anti-cancer therapy. <em>Clin. Transl. Med.</em><strong>12</strong>(5), e822 (2022).
</cite> [<a href="https://doi.org/10.1002/ctm2.822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9121317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35593206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou,%20M.%20et%20al.%20The%20role%20of%20cell-penetrating%20peptides%20in%20potential%20anti-cancer%20therapy.%20Clin.%20Transl.%20Med.12(5),%20e822%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Razak, N. A. et al. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. <em>Sci. Rep.</em><strong>9</strong>(1), 1514 (2019).
</cite> [<a href="https://doi.org/10.1038/s41598-018-37796-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6365513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30728391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Razak,%20N.%20A.%20et%20al.%20Cytotoxicity%20of%20eupatorin%20in%20MCF-7%20and%20MDA-MB-231%20human%20breast%20cancer%20cells%20via%20cell%20cycle%20arrest,%20anti-angiogenesis%20and%20induction%20of%20apoptosis.%20Sci.%20Rep.9(1),%201514%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Fard, S. S., Jeddi-Tehrani, M., Akhondi, M. M., Hashemi, M. &amp; Ardekani, A. M. Flow cytometric analysis of 4-HPR-induced apoptosis and cell cycle arrest in acute myelocytic leukemia cell line (NB-4). <em>Avicenna J. Med. Biotechnol.</em><strong>2</strong>(1), 53–61 (2010).
</cite> [<a href="/articles/PMC3558144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23407328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fard,%20S.%20S.,%20Jeddi-Tehrani,%20M.,%20Akhondi,%20M.%20M.,%20Hashemi,%20M.%20&amp;%20Ardekani,%20A.%20M.%20Flow%20cytometric%20analysis%20of%204-HPR-induced%20apoptosis%20and%20cell%20cycle%20arrest%20in%20acute%20myelocytic%20leukemia%20cell%20line%20(NB-4).%20Avicenna%20J.%20Med.%20Biotechnol.2(1),%2053%E2%80%9361%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Abdullah, H., Ismail, I., Suppian, R. &amp; Zakaria, N. M. Natural gallic acid and methyl gallate induces apoptosis in hela cells through regulation of intrinsic and extrinsic protein expression. <em>Int. J. Mol. Sci.</em><strong>24</strong>(10), 8495 (2023).
</cite> [<a href="https://doi.org/10.3390/ijms24108495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10218240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37239840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abdullah,%20H.,%20Ismail,%20I.,%20Suppian,%20R.%20&amp;%20Zakaria,%20N.%20M.%20Natural%20gallic%20acid%20and%20methyl%20gallate%20induces%20apoptosis%20in%20hela%20cells%20through%20regulation%20of%20intrinsic%20and%20extrinsic%20protein%20expression.%20Int.%20J.%20Mol.%20Sci.24(10),%208495%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Qian, J. et al. Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers. <em>J. Immunother. Cancer</em><strong>12</strong>(1), e008145 (2024).
</cite> [<a href="https://doi.org/10.1136/jitc-2023-008145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10824003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38267222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qian,%20J.%20et%20al.%20Development%20of%20therapeutic%20monoclonal%20antibodies%20against%20DKK1%20peptide-HLA-A2%20complex%20to%20treat%20human%20cancers.%20J.%20Immunother.%20Cancer12(1),%20e008145%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Pozarowski, P. &amp; Darzynkiewicz, Z. Analysis of cell cycle by flow cytometry. <em>Methods Mol. Biol.</em><strong>281</strong>, 301–311 (2004).
</cite> [<a href="https://doi.org/10.1385/1-59259-811-0:301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15220539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pozarowski,%20P.%20&amp;%20Darzynkiewicz,%20Z.%20Analysis%20of%20cell%20cycle%20by%20flow%20cytometry.%20Methods%20Mol.%20Biol.281,%20301%E2%80%93311%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Liu, H., Dai, L., Wang, M., Feng, F. &amp; Xiao, Y. Tunicamycin induces hepatic stellate cell apoptosis through calpain-2/Ca<sup>2+</sup>-dependent endoplasmic reticulum stress pathway. <em>Front. Cell Dev. Biol.</em><strong>9</strong>, 684857 (2021).
</cite> [<a href="https://doi.org/10.3389/fcell.2021.684857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8484751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34604209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20H.,%20Dai,%20L.,%20Wang,%20M.,%20Feng,%20F.%20&amp;%20Xiao,%20Y.%20Tunicamycin%20induces%20hepatic%20stellate%20cell%20apoptosis%20through%20calpain-2/Ca2+-dependent%20endoplasmic%20reticulum%20stress%20pathway.%20Front.%20Cell%20Dev.%20Biol.9,%20684857%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Chatnarin, S. &amp; Thirabunyanon, M. Potential bioactivities via anticancer, antioxidant, and immunomodulatory properties of cultured mycelial enriched β-D-glucan polysaccharides from a novel fungus Ophiocordyceps sinensis OS8. <em>Front. Immunol.</em><strong>14</strong>, 1150287 (2023).
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1150287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10126296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37114040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chatnarin,%20S.%20&amp;%20Thirabunyanon,%20M.%20Potential%20bioactivities%20via%20anticancer,%20antioxidant,%20and%20immunomodulatory%20properties%20of%20cultured%20mycelial%20enriched%20%CE%B2-D-glucan%20polysaccharides%20from%20a%20novel%20fungus%20Ophiocordyceps%20sinensis%20OS8.%20Front.%20Immunol.14,%201150287%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Khan, H. et al. Structure based docking and biological evaluation towards exploring potential anti-cancerous and apoptotic activity of 6-Gingerol against human prostate carcinoma cells. <em>BMC Complement. Med. Therapies</em><strong>24</strong>(1), 8 (2024).</cite> [<a href="https://doi.org/10.1186/s12906-023-04269-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10759763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38166796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khan,%20H.%20et%20al.%20Structure%20based%20docking%20and%20biological%20evaluation%20towards%20exploring%20potential%20anti-cancerous%20and%20apoptotic%20activity%20of%206-Gingerol%20against%20human%20prostate%20carcinoma%20cells.%20BMC%20Complement.%20Med.%20Therapies24(1),%208%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12368056/bin/41598_2025_13110_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (2.3MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-13110-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_13110.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (12.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368056/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368056/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368056%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368056/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368056/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368056/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40835666/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368056/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40835666/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368056/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368056/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6ATkOdD8CWpoJSE5decFA6zSq3aoHhSD566o77sIhXn2rFsWILljEPr2qoUD6AjD">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
